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ABSTRACT OF THESIS 
 
 
THE IMPACT OF DYSPHAGIA AND GASTROSTOMY ON QUALITY OF LIFE IN 
CAREGIVERS OF PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS 
 
There is little research studying the relationship between caregiver quality of life 
and gastrostomy, a palliative intervention recommended to manage dysphagia and 
malnutrition in patients diagnosed with Amyotrophic Lateral Sclerosis (ALS). To 
facilitate a more comprehensive assessment of treatment effectiveness and to better guide 
patients and their families, this study investigated the relationship between gastrostomy, 
caregiver strain, and patient disease-related factors. Patients with bulbar-onset ALS and 
their caregivers were recruited regardless of their decision to accept or decline future 
gastrostomy. Caregivers completed the Modified Caregiver Strain Index (MCSI) to 
assess levels of caregiver strain as an index of quality of life. Surveys were completed at 
3-month intervals prior to gastrostomy and at a single time point following gastrostomy. 
Of 13 patient-caregiver dyads recruited, 1 dyad completed both phases of the study as of 
yet. This caregiver reported increased caregiver strain following gastrostomy. Medical 
interventions aimed at managing dysphagia, such as gastrostomy, may not have a 
predictable impact on caregiver strain, as indexed by the MCSI, or changes in caregiver 
strain may reflect characterological differences among patient-caregiver dyads. Other 
psychosocial factors within a given patient-caregiver dyad may be stronger predictors of 
caregiver strain, burden, and quality of life in caregivers. 
 
KEYWORDS: Amyotrophic lateral sclerosis, dysphagia, gastrostomy, quality of life, 
caregiver strain, caregivers 
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Chapter One:  Introduction 
Commensality, the act of eating with other people, is considered by many social 
scientists to hold a unique sociological, psychological, and anthropological value for 
human beings (Fischler, 2011; Sobal & Nelson, 2003). People often choose to share their 
daily meals in common meal despite being able to meet nutritional needs alone. Our 
selections in cuisine, methods of preparation, and commensal partners often extend 
beyond considerations of energy and nutritional nourishment and are inextricably linked 
to our social, cultural, and psychological quality of life (Barr & Schumacher, 2003). 
Given the deleterious effects on commensality by a disruption in an individual’s ability to 
safely swallow, one would expect a resultant negative impact on quality of life. 
Amyotrophic lateral sclerosis (ALS) unequivocally does just this not only to the 
diagnosed individual but also to their partners, family members, and friends.  
ALS is a progressive, terminal neurodegenerative disease characterized by the 
gradual denervation of motor neurons in the brain, brainstem, and spinal cord, ultimately 
resulting in paralysis of the voluntary muscles responsible for movement, speech, 
swallowing, and breathing (Wijesekera & Leigh, 2009). It is estimated that 5,600 
individuals are diagnosed with ALS each year, with most individuals developing the 
disease between the ages of 40 and 70 years old (Robert Packard Center for ALS 
Research at Johns Hopkins, 2019). ALS is often described in three distinct clinical 
phenotypes depending on the origin of symptom onset within particular groups of 
muscles: spinal, bulbar, or respiratory (McDermott & Shaw, 2008). Bulbar-onset ALS, 
which follows a rapidly progressive and predictable course, is typified by symptoms 
emerging within the bulbar region of the brainstem, which houses the cranial nerves 
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responsible for speech, swallowing, and salivation (Hillel & Miller, 1989). The gradual 
loss of motor control in the bulbar musculature is considered, by some, to epitomize the 
most distressing and alienating symptoms of ALS: the loss of the ability to speak and 
swallow. Although bulbar symptoms are only part of the initial disease presentation in 
approximately 15-30% of individuals diagnosed with ALS, up to 85% of patients will 
eventually develop bulbar symptoms as motor neuron deterioration spreads to other 
muscle groups (Onesti et al., 2017). Onset of bulbar symptoms is a negative prognostic 
indicator, with some studies reporting a median survival range of 2 to 3 years from the 
earliest presentation of bulbar signs (Howard & Orrell, 2002; Mazzini et al., 1995; 
Stambler, Charatan, & Cedarbaum, 1998). Given the markedly reduced survival range 
and potentially traumatic symptoms experienced by patients diagnosed with bulbar onset 
ALS, it is imperative for medical recommendations and treatments to consider comfort 
and quality of life of the patient and their family. 
Dysphagia, defined as difficulty in moving food or liquid from the mouth to the 
stomach, is an inevitable clinical symptom faced by individuals with bulbar onset ALS 
(Ruoppolo et al., 2013). Oral feeding ability becomes more inefficient and tiresome due 
to the progressive weakness and spasticity of the muscles involved in mastication and 
oral preparation (Rosenfeld & Strong, 2015). Concomitant impairments in limb mobility 
contribute to the individual’s reduced ability to self-feed and maintain daily caloric 
needs. In addition to a reduction in the efficiency of swallowing, the safety of swallowing 
is simultaneously jeopardized. Deterioration in the respiratory, laryngeal, and pharyngeal 
musculature leads to reduced cough capacity and impaired airway protection, which 
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places the individual at risk for choking episodes, tracheal aspiration, and aspiration 
pneumonia (Park, Kang, Lee, Choi, & Kim, 2010). 
While it is well established that dysphagia negatively impacts the swallowing-
related quality of life of individuals diagnosed with ALS, it is unknown how dysphagia 
adversely affects quality of life in their caregivers as this assumption has been 
insufficiently studied (da Costa Franceschini & Mourao, 2015; Paris et al., 2013; Tabor, 
Gaziano, Watts, Robison, & Plowman, 2016). The responsibility of providing care to an 
individual diagnosed with ALS usually falls to the individual’s partner or closest family 
member, and feeding was reported as the second most time-consuming task for 
caregivers of individuals with ALS (Chio et al., 2006). Additionally, the time devoted to 
caregiving, estimated to range from 5-15 hours per day, only increases with the 
progression of disease severity (Krivickas, Shockley, & Mitsumoto, 1997). This 
inevitability of increased caregiver strain for the caregiver highlights the importance of 
considering interventions that aim to improve, or at least maintain, the quality of life for 
both the patient and informal caregiver (Lo Coco et al., 2005). 
While there is currently no known cure for ALS, various palliative interventions 
are employed to alleviate symptoms, prolong survival, promote independence, and 
maintain quality of life (Kiernan et al., 2011; McDermott & Shaw, 2008; Miller et al., 
2009). To manage early dysphagic symptoms, compensatory strategies, including 
postural adjustments and dietary modifications, are recommended to increase the safety 
and efficiency of swallowing and maintain adequate nutrition and hydration (Wijesekera 
& Leigh, 2009). As frequently reported in the literature, management of dysphagia often 
falls upon a spouse or close family member of the patient due to the progressive physical 
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limitations and fatigue characteristic of the disease as well as the prohibitive costs of 
employing a professional caregiver (Stavroulakis et al., 2014, 2016; M. Trail, Nelson, 
Van, Appel, & Lai, 2004). Informal caregivers, who likely have very little training in 
dysphagia management, find themselves responsible for managing and troubleshooting 
the difficulties associated with eating and swallowing. Caregivers may experience 
increased caregiver strain due to the demands of food preparation for frequent small 
meals, compounding the substantial amount of time and effort already devoted to other 
routine care of the patient. Anecdotal and clinical observations suggest that family of 
individuals with dysphagia may also experience fear and anxiety due to the risk of their 
loved one choking or aspirating during a meal and the need for the caregiver to be 
physically present during all meals to assist with feeding or intervene if choking 
(Kasarskis, 2017; Stavroulakis et al., 2014). Mealtimes that were once a pleasurable, 
social experience devolve into a prolonged, taxing endeavor for both the individual 
diagnosed with ALS and their caregiver. 
As dysphagic symptoms worsen in the presence of deteriorating bulbar 
musculature, early symptomatic management of dysphagia becomes less effective (J. 
Johnson et al., 2012; Radunović, Mitsumoto, & Leigh, 2007). The association between 
weight loss, malnutrition, and shortened survival in individuals with ALS has been 
previously demonstrated (Desport et al., 1999; Limousin et al., 2010). To counter the 
negative effects of malnutrition and weight loss, the American Academy of Neurology 
(AAN) recommends gastrostomy as an alternative or supplemental route to oral feeding 
(Miller et al., 2009; Miller et al., 1999). Current practice guidelines recommend 
gastrostomy tube insertion in patients with worsening dysphagia in the presence of 
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inability to maintain caloric requirements, weight loss greater than 10% of premorbid 
body weight, or forced vital capacity of 50% less than predicted value (Kasarskis et al., 
2014).  
The purported benefits of gastrostomy include weight stabilization, improved 
nutritional and fluid intake, and a safer route for medication; however, the evidence base 
on prolonging length of survival is equivocal and lacking in randomized controlled trials 
(Burkhardt, Neuwirth, Sommacal, Andersen, & Weber, 2017; Desport et al., 1999; 
Katzberg & Benatar, 2011; Mazzini et al., 1995; McDonnell, Schoenfeld, Paganoni, & 
Atassi, 2017; Mitsumoto et al., 2003; ProGas Study Group, 2015; Radunović et al., 2007; 
Spataro, Ficano, Piccoli, & La Bella, 2011; Stavroulakis, Walsh, Shaw, McDermott, & 
ProGas Study Group, 2013). Additionally, the impact of this specific medical 
intervention on quality of life in individuals with ALS and their caregivers lacks rigorous 
examination even though quality of life may be considered of critical importance in the 
discussion for or against gastrostomy. In the most recent Cochrane Review of enteral tube 
feeding in individuals diagnosed with ALS, only 20% of those individuals who met the 
criteria for enteral support actually accepted gastrostomy tube insertion (Katzberg & 
Benatar, 2011). This suggests that both physicians and patients are ambivalent about the 
value of gastrostomy. Perhaps the decision to proceed with gastrostomy must extend 
beyond objective medical criteria and consider psychological and psychosocial factors of 
the patient and their family (Brotherton & Abbott, 2009; Stavroulakis et al., 2013). In the 
face of terminal illness as overwhelming as ALS, quality of life must be considered a 
critical focus of our clinical care of this vulnerable population (Hardiman, Hickey, & 
O’Donerty, 2004). 
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Statement of the Problem 
The decision to accept or decline gastrostomy must be guided by the preferences 
of the individual and their family, goals of treatment, and outcome data (DeLegge et al., 
2005). ALS is a devastating disease for patients and their family members, and healthcare 
professionals need to provide clear, objective information regarding the anticipated 
benefits and burdens of gastrostomy (Squires, 2006). As of yet, the impact of gastrostomy 
on quality of life in individuals diagnosed with ALS and their caregivers has been 
insufficiently researched. Lacking an evidence-based understanding of the impact of 
gastrostomy on quality of life effectively inhibits informed, autonomous decision making 
among patients and their families. Due to the lack of effective pharmacotherapy, 
treatments that maximize quality of life in the individual and their family are critically 
important (Galvin et al., 2015; McDermott & Shaw, 2008). Physiologic improvement, 
e.g., increased weight gain, nutrition, hydration, and length of survival, in the absence of 
psychologic improvement, e.g., quality of life, may be perceived as little benefit for some 
individuals (Kurien et al., 2017). And worse, it is possible that for some individuals, 
gastrostomy effectively prolongs a debilitating state of reduced quality of life (Simmons, 
2015). It is vital to obtain a comprehensive assessment of the treatment effectiveness of 
gastrostomy, including how this specific medical intervention impacts the quality of life 
in all individuals involved in the healthcare decision-making process (both patients and 
their caregivers).  
Social support has been rated as one of the biggest determinants of quality of life 
in patients diagnosed with ALS, and multiple studies have documented the 
interdependence of patient and caregiver quality of life (Boerner & Mock, 2012; 
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Simmons, Bremer, Robbins, Walsh, & Fischer, 2000). Medical treatments that alleviate 
caregiver strain may improve the quality of care and social support provided to the 
patient. Gastrostomy is often recommended with the anticipation of a subsequent 
alleviation in the caregiver’s physical burden of meal preparation and emotional burdens 
such as anxiety and fear surrounding the patient’s swallowing and nutritional status. 
Quality of life in both patients and caregivers needs to be investigated as an outcome 
measure of treatment to remain consistent with the holistic person- and family-centered 
approach fundamental to palliative care (Hughes, Sinha, Higginson, Down, & Leigh, 
2005; S. Johnson et al., 2017). Research into the effect of gastrostomy on caregiver 
quality of life aims to accomplish a more comprehensive understanding of the medical 
intervention’s effectiveness and efficiency and, simultaneously, carer-proof the decision-
making process (Al-Janabi, Nicholls, & Oyebode, 2016). Medical interventions that 
increase caregiver strain may decrease the effectiveness of the care they can provide and 
ultimately result in a cascade of negative ramifications. Thus, it is imperative to obtain a 
comprehensive assessment of the impact of gastrostomy on all individuals involved in the 
decision-making process.  
Purpose of the Study 
The AAN has called for further investigation via prospective trials to guide 
healthcare professionals in the treatment of individuals with ALS (ProGas Study Group, 
2015). There is a need for a rigorous investigation into how gastrostomy impacts quality 
of life in caregivers of patients with ALS. This study ultimately aims to contribute to the 
understanding of the treatment efficacy of gastrostomy to better guide patients and their 
families in the decision to accept or decline gastrostomy and optimize the timing of 
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clinical recommendations for gastrostomy tube insertion. This study evaluates the impact 
of gastrostomy on quality of life in caregivers of patients with ALS and dysphagia. In the 
absence of randomized controlled trials, this study employed a prospective, longitudinal 
investigation into the quality of life of caregivers of patients diagnosed with ALS and 
neurogenic dysphagia through the decision to accept or decline gastrostomy.  
Chapter Summary 
Chapter 1 served to introduce dysphagia in individuals diagnosed with ALS, the 
impact of dysphagic symptoms on the individual and their family, and the current clinical 
recommendations and its implications on quality of life in both individuals diagnosed 
with ALS and their caregivers. Chapter 2 will comprise a review on the current literature 
investigating quality of life in caregivers of individuals with ALS and neurogenic 
dysphagia. 
 
 
 
 
 
 
 
Copyright © Emily Clare Sither Goggin 2019 
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Chapter Two:  Literature Review 
The purpose of this literature review is to assess the extant literature relevant to 
determining the relationship between gastrostomy and quality of life in caregivers of 
patients with ALS and neurogenic dysphagia.  
Caregiver Quality of Life 
Caregiving is considered a “fertile ground for persistent stress” (Pearlin, Mullan, 
Semple, & Skaff, 1990, p. 583). The importance of considering the physical and 
emotional wellbeing of the caregiver of an individual diagnosed with a terminal illness 
can hardly be overstated. Caregivers who become overly burdened or stressed are at 
increased risk of compromises in their physical and/or emotional health, which impacts 
the care they provide to the care recipient (Cousins, Davies, Turnbull, & Playfer, 2002) . 
Although subsequent sections of this literature review accomplish an in-depth exploration 
of quality of life in caregivers of patients with ALS and/or dysphagia, some brief points 
on the broader topic of caregiving are necessary.  
Scientific pursuits in caregiving research lack consensus in conceptualization and 
operationalization (Chou, 2000). Caregiver burden, caregiver strain, caregiver distress, 
and caregiver stress are often used interchangeably within the terminology of caregiver 
outcomes, and there is little agreement on the individual definitions of these terms 
(Braithwaite, 1992; Thornton & Travis, 2003). Consequently, there is great variability in 
conclusions regarding the main determinants of caregiver burden, caregiver strain, and 
caregiver distress and a simultaneous hindrance in the devising of suitable assessments to 
anticipate or identify vulnerable caregivers. Some studies reported patient-specific 
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impairments, disease progression, and duration spent in the role of caregiving were most 
influential in levels of caregiver burden and strain (Crespo, Lopez, & Zarit, 2005; Zarit, 
2004). Other authors have disagreed, arguing that caregiver outcomes are more related to 
the variables that the caregiver brings to the caregiving situation, including personality 
traits and mental states (Burke et al., 2018; Cousins et al., 2002; Cumming & De 
Miranda, 2012; S. Johnson et al., 2017; Simmons et al., 2000; Zanetti et al., 1998). 
Poulshock and Diemling argued that caregiver burden could be conceived of as a 
psychological concept wherein “burden” is constituted by a caregiver’s subjective 
interpretation of how their wellbeing is impacted by the difficulties pursuant to the 
patient’s impairments and demands of the caregiving role (as cited in Cousins et al., 
2002, p. 388). Viewing caregiver burden as a subjective phenomenon lends support to the 
findings of vastly different caregiver outcomes in similar caregiving situations. 
Regardless of the lack of consensus in the caregiving literature, the caregiver’s 
experience of increased caregiver burden/strain, reduced quality of life, and the increased 
propensity for this sequalae to surface during long-term care situations should not be 
minimized. Some authors conceived of the relationship between caregiver characteristics, 
caregiver strain, and caregiver quality of life within a “chains-of-risk” model (Litzelman 
et al., 2015). Caregiver strain is a function of a cluster of risk factors encompassing 
caregiver characteristics, demographics, and environmental resources. The accumulation 
of these risk factors through increased caregiver strain negatively impacts the health and 
quality of life of the caregiver. Previous studies highlighted the need to conduct early 
assessments of self-perceived levels of strain, burden, and quality of life in caregivers 
within long-term caregiving situations, and intervene before caregiver outcomes reach 
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clinically significant levels (Al-Janabi et al., 2016; Thornton & Travis, 2003). Further 
analysis into the conceptualization and operationalization of burden, strain, distress, and 
stress in caregivers of patients with chronic illnesses is beyond the scope of this study. 
For the purposes of this study, caregiver strain was considered an index of quality of life 
in caregivers. What follows is an exploration of the literature evaluating caregiver strain, 
burden, emotional and psychosocial characteristics, and quality of life in caregivers of 
patients with ALS and/or dysphagia. 
Quality of Life in Caregivers of Patients with ALS 
The concept of quality of life is multifaceted, broad-ranging, and difficult to 
define as either a quantitative or qualitative outcome measure (Hardiman et al., 2004). 
Understandably then, researchers have employed a variety of instruments in studying it. 
Pursuant to methodological disparities, it is difficult to discern and track commonalities 
in research results. However, there is broad consensus among researchers that quality of 
life among caregivers of patients with ALS may be significantly compromised by the 
challenges associated with the care of a patient suffering from a neurological disease (S. 
Johnson et al., 2017). 
Much of the literature involving caregivers of patients with ALS has focused on 
how the disease and its inevitable progression may impact caregiver quality of life, 
psychosocial wellbeing, and levels of caregiver burden. The majority of studies have 
shown that the impact on caregiver quality of life has been negative. Investigators have 
found that the disease may negatively impact the caregivers’ physical or psychological 
well-being (Krivickas et al., 1997). Significant levels of caregiver burden have been 
reported, and this burden is likely to increase as the disease worsens (Chio, Gauthier, 
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Calvo, Ghiglione, & Mutani, 2005; Gelinas, O’Connor, & Miller, 1998). According to 
Burke et al., approximately 50% of caregivers of patients with ALS report clinically 
significant levels of burden, highlighting the importance of considering caregiver burden 
and investigating interventions that may alleviate burden and improve quality of life in 
caregivers (Burke et al., 2017). Self-perceived quality of life among caregivers is 
adversely affected, and their satisfaction with life may significantly decrease (Bromberg 
& Forshew, 2002; Jenkinson, Fitzpatrick, Swash, & Peto, 2000; Lo Coco et al., 2005; 
Roach, Averill, Segerstrom, & Kasarskis, 2009). 
However, other studies have reported that caregivers of patients with ALS rate 
their quality of life as fairly good (Marilyn Trail, Nelson, Van, Appel, & Lai, 2003). 
According to one study, while caregiver distress, anxiety, and depression were observed 
to increase over the course of the disease, these ratings did not meet pathological levels 
(Gauthier et al., 2007). Other studies have sought to understand if there is concordance 
between patient and caregiver in terms of quality of life and psychological factors; 
however, no broad consensus has emerged from these studies (Chio et al., 2005; 
Goldstein, Atkins, Landau, Brown, & Leigh, 2006; Jenkinson et al., 2000; Lo Coco et al., 
2005; Olsson Ozanne, Strang, & Persson, 2010; Rabkin, Wagner, & Del Bene, 2000). 
Other literature is largely dedicated to investigating the contributors, predictors, and 
protective factors of caregiver quality of life, burden, strain, and distress rather than the 
impact of medical interventions such as gastrostomy (Burke et al., 2017; Burke et al., 
2018; Chio et al., 2004; Gauthier et al., 2007). Due to the varied findings of quality of life 
in caregivers of patients with ALS, there is a need for a systematic study evaluating the 
burden of disease progression on caregivers. 
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While the aforementioned literature sets out to explore quality of life and burden 
of caregivers of patients with ALS in a broader context, there are fewer studies exploring 
how dysphagia specifically impacts caregiver quality of life. Additionally, there is very 
little research studying the nature of the relationship between caregiver quality of life and 
palliative interventions that manage dysphagia. In the subsequent sections, previous 
research into quality of life is explored from the unique perspective of caregivers who 
provide informal care to individuals with dysphagia, beginning first with literature on 
dysphagia as a result of non-ALS diagnoses and then leading into dysphagia due to ALS. 
Quality of Life in Caregivers of Patients with Dysphagia 
In studies conducted with caregivers of patients with dysphagia following stroke 
and traumatic brain injury, caregivers described how the cooking and serving of food 
became a vitally important task (Johansson & Johansson, 2009). They would spend a 
significant amount of time preparing a meal that was simultaneously safe, nourishing, and 
appetizing. For individuals who provide care to patients with dysphagia following non-
surgical management for head and neck cancer, dysphagia can produce activity 
limitations and participation restrictions (Nund et al., 2014). Through thematic analysis of 
semi-structured interviews with 12 caregivers of patients with dysphagia without 
gastrostomy, researchers identified clinically significant levels of distress and decreased 
quality of life. Caregivers reported a sense of ill-preparedness when it came to the 
fulfilling their role in the management of dysphagia and its negative impact on meal 
preparation, social activities, and daily life as a family.  
In patients with dysphagia who underwent chemoradiotherapy for treatment of 
head and neck cancer, 19 caregivers were asked to complete the Caregiver Quality of 
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Life Index-Cancer tool (CQOL-C) (Patterson, Rapley, Carding, Wilson, & McColl, 
2013). Caregiver-dyads were only included in the study if the caregivers participated in 
meal provision and if patients reported experiencing dysphagia, as indexed by a score of 
less than 80 points on the M.D. Anderson Dysphagia Inventory (MDADI). No significant 
differences were observed in caregiver quality of life between pre-treatment and 3-
months post-treatment; however, a significant improvement was observed in the ‘burden’ 
domain of the CQOL-C between three- and 12-months post-treatment. Authors reported a 
gradual decline in the number of patients who were reliant on gastrostomy during this 
period: 17 patients had gastrostomy at three-months post-treatment and only 11 patients 
had gastrostomy at 12-months post-treatment. Caregivers of patients who were 
gastrostomy-dependent at three-months post-treatment and 12-months post-treatment 
reported significantly lower quality of life scores on the CQOL-C. Authors concluded 
that with the increased requirements in the physical care of the patient’s dysphagia comes 
with reduced quality of life reported in caregivers.  
Dysphagia was associated with increased caregiver burden in all four studies 
selected for systematic review, although a divergence was observed in the tools used to 
measure caregiver burden (Namasivayam-MacDonald & Shune, 2018). Increases in 
general burden levels for caregivers was associated with self-reported difficulties in 
swallowing, gradual decline in feeding behaviors, and the operation of feeding tubes. 
Self-reported levels of emotional and psychological burden were related to the 
caregiver’s concerns over the patient’s nutritional intake, counterbalancing choking risks 
with desirable foods, and the conflicting process of accepting gastrostomy as eventuality. 
The authors of this systematic review highlighted the importance of understanding how 
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dysphagia may contribute to caregiver burden and the need for successful, evidence-
based interventions that alleviate caregiver burden and, therefore, improve the quality of 
life of both the patient and the caregiver.  
Building on the momentum of this systematic review, the same authors conducted 
a cross-sectional study of community-dwelling elderly adults and their spousal caregivers 
to further elucidate the type (financial, emotional, and/or physical burden) and degree of 
caregiver burden experienced by spouses of individuals with dysphagia (Shune & 
Namasivayam-MacDonald, 2019). Of the 422 care recipients surveyed, 17% of care 
recipients reported swallowing difficulties, and a significant association was found 
between the care recipient’s self-reported dysphagia status and their respective 
caregiver’s increased levels of emotional burden. For caregivers of spouses with 
swallowing difficulties, 70% of caregivers endorsed moderate to severe levels of 
emotional burden, 50% reported feeling depressed or hopeless within the past month, and 
60% indicated their personal time was decreased due to the time devoted to caregiving. 
Despite the inherent limitations of self-reporting and cross-sectional analyses, clear 
methodological weaknesses were noted. Dysphagia status was determined via a single 
question posed to the care recipient: “any problems while chewing or swallowing while 
eating in the past month?” (Shune & Namasivayam-MacDonald, 2019, p. 5). Also, the 
presence or absence of caregiver burden was evaluated via a simple 5-point Likert scale. 
However, the results of this study cannot be ignored—dyadic health needs to be 
prioritized since the health and well-being of the caregiver and the care recipient are 
interdependent. Authors intimated the need for further longitudinal investigation into this 
association: what caregiver variables, care recipient variables, and/or dyadic variables 
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contribute to, or moderate, the relationship between the presence of dysphagia in care 
recipients and increased levels of emotional burden in caregivers? 
Other authors evaluated the anxiety levels of caregivers of patients with 
neurological disorders, both with and without neurogenic dysphagia (Serel Arslan, 
Demir, & Karaduman, 2017). Based on the presence of dysphagia, participants were 
assigned to either the study group (dysphagic) or the control group (non-dysphagic). Of 
particular relevance to the present study, 24 of the 103 adult neurological patients 
assigned to the dysphagic study group were diagnosed with ALS. Results showed that 
caregivers of neurological patients with dysphagia reported higher momentary and long-
lasting anxiety levels compared to caregivers of neurological patients without dysphagia. 
However, surprisingly, no relationship was observed between anxiety levels of caregivers 
and the severity of patients’ dysphagia, types of feeding, or the degree of dependency of 
patient to caregiver. The authors concluded that the additional burden dysphagia placed 
on caregivers may be explained by four factors including chronic disruption in daily life 
of both caregiver and patient: diminution of valued social aspects of mealtimes, education 
of the caregiver and designation of the caregiver as the primary bearer of responsibility 
for the management of dysphagic symptoms in the patient, and potential feelings of 
insecurity or incapability in regard to administration of safe oral intake and symptom-
related problem solving. This is highly relevant to our current research as it is the first 
study that includes a population of ALS caregivers (albeit only a small subset of the 
sample) when investigating the impacts of dysphagia on the caregiver. This study 
emphasizes the vital role caregiver involvement plays in dysphagia management, and 
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suggests that large, prospective studies are needed to evaluate the impact of dysphagia on 
ALS caregivers and potential interventions that alleviate caregiver burden. 
Quality of Life in Caregivers of Patients with ALS and Dysphagia 
Although the impact of dysphagia on quality of life of ALS caregivers has not 
undergone rigorous examination, some insight has surfaced through qualitative, 
retrospective studies that investigated the perspectives of patients, caregivers, and 
healthcare professionals regarding the decision to proceed with or forgo gastrostomy.  
In a retrospective study exploring the perspectives of 10 patients and eight 
caregivers regarding the decision to proceed with gastrostomy insertion, participants 
described how the challenges of food preparation had a negative impact on both the 
caregiver’s and the patient’s quality of life (Stavroulakis et al., 2014). Altering food 
consistencies and thickening liquids was described as time consuming and, according to 
one patient-caregiver dyad, restricted their ability to travel since “the hotel couldn’t 
handle it… they couldn’t prepare the food in the way that was necessary.” Other factors 
that were influential in the decision to proceed with gastrostomy insertion included 
significant weight loss, prolonged and effortful meals, and reduced swallow safety with 
frequent occurrences of choking, aspiration, and chest infection. While this small sample 
provided unique insight into the decision-making process of gastrostomy, it also 
highlighted the need for further investigation of the potential benefits of gastrostomy to 
assist patients and caregivers in making informed, timely decisions on whether they 
wished to proceed or forgo gastrostomy tube insertion.  
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In another study qualitative study, researchers interviewed healthcare 
professionals of patients with ALS to identify the diverse factors involved in the 
decision-making process of gastrostomy and discovered that the perceived effect on the 
patient’s quality of life and the impact of the procedure on the family was pivotal in the 
decision to accept or decline gastrostomy (Martin et al., 2016). Many healthcare 
professionals reported the patient agreed to the gastrostomy procedure due to the positive 
impact they hoped it might have on their family while other healthcare professionals 
considered the patients’ fear of the negative impact of gastrostomy on their family to be a 
decisive factor in the refusal of the intervention. For example, one healthcare professional 
stated, “[the caregiver] does everything for her… He’s worn out, he’s tired… I think it 
probably did [affect her decision]… I don’t think she could put another thing on [the 
caregiver]” (Martin et al., 2016, p. 1372). The selection of healthcare professionals who 
were interviewed in this study was determined by the patients themselves; thus, the 
generalizations of these findings are limited. However, the authors provided valuable 
insights to support people with ALS and their caregivers. Ultimately, the authors’ work 
implied a continued need for more evidence-based research on the impact of gastrostomy 
on the quality of life of patients and caregivers to facilitate informed decision-making 
regarding gastrostomy as a medical intervention. 
Gastrostomy and Quality of Life in Caregivers of Patients with ALS 
There is a paucity of research exploring the impact of gastrostomy on quality of 
life in patients with ALS and the findings, thus far, are equivocal (Katzberg & Benatar, 
2011; Körner et al., 2013; Mazzini et al., 1995; McDonnell et al., 2017; Mitsumoto et al., 
2003; ProGas Study Group, 2015; Zamietra et al., 2012). Similarly, there is a dearth of 
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research regarding the effects of gastrostomy on the caregiver’s quality of life. Two 
retrospective studies and one prospective study are explored below. 
Mitsumoto et al. conducted a stratified case-control study by retrospectively 
analyzing data derived from the ALS Patient Care Database (Mitsumoto et al., 2003). No 
significant differences were observed in caregiver burden between caregivers of patients 
with gastrostomy tubes and caregivers of patients without gastrostomy tubes; however, 
the instrument used to evaluate caregiver burden remained unclear. Authors concluded 
that these findings could be explained by either of the following observations: patients 
who proceeded with gastrostomy were farther along in disease progression and required 
greater amounts of care, or the instrument used to assess caregiver burden may not have 
been sensitive to the changes brought about by gastrostomy tube insertion. To properly 
investigate the question of whether gastrostomy tube insertion and use reduces the burden 
in caregivers, a prospective study utilizing sensitive, specific instruments to evaluate 
caregiver burden is needed. 
In a retrospective, qualitative exploration, patients and caregivers described both 
challenges and benefits of gastrostomy (Stavroulakis et al., 2016). In the absence of 
alternatives, patients and caregivers described the potential benefits as outweighing the 
negatives; although, significant psychosocial concerns were noted. The benefits of 
gastrostomy included anxiety relief in both patients and caregivers, weight stabilization in 
patients, and prolonged survival. Researchers noted that concerns among some patient-
caregiver dyads included the inability of patient and caregiver to share a meal, and its 
potential contribution to feelings of social isolation and depression, as well as caregiver 
discomfort and/or guilt when eating in the patient’s presence, and finally the time and 
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burden associated with food administration and maintenance of gastrostomy equipment. 
These findings, although providing useful insight into the psychosocial concerns 
associated with gastrostomy, are limited due to small sample size as well as their 
retrospective character—findings were based on interviews with patients after they 
elected to proceed with gastrostomy. Another limitation of the study may explain, at least 
in part, the reason for inability to share a meal together; all patients interviewed in this 
study opted for late gastrostomy insertion and none maintained oral intake following the 
procedure. Earlier gastrostomy tube insertion may have yielded different results. The 
psychosocial impact of gastrostomy may be different in patients who elect for early 
gastrostomy insertion in anticipation of bulbar symptoms, and/or patients who opt to 
employ a combination of gastrostomy and oral intake for as long as tolerated.  
Previous authors described how combining oral intake with enteral feeding after 
gastrostomy insertion may be beneficial for patients to gradually adapt to their new 
lifestyle and simultaneously improve their nutritional status while prolonging survival 
(Spataro et al., 2011; Squires, 2006). Patients may continue oral intake for pleasure until 
it becomes too distressing or they are unable to initiate a swallow. In the University of 
Kentucky ALS Multidisciplinary Clinic, patients are encouraged to continue eating and 
drinking as tolerated and for pleasure in addition to using the feeding tube. Future 
research should include a large sample of patients-caregiver dyads enrolled prior to the 
gastrostomy decision and followed longitudinally to further elucidate the impact of 
gastrostomy on patient and caregiver quality of life. 
In a large, multi-center, prospective, longitudinal study, investigators recruited 
345 patients with ALS and their caregivers to evaluate the changes in patient self-
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perceived quality of life and caregiver strain following gastrostomy (ProGas Study 
Group, 2015). At baseline, before the gastrostomy procedure, and at 3-months following 
gastrostomy, patients completed the McGill Quality of Life questionnaire, and informal 
caregivers completed the Modified Caregiver Strain Index (Thornton & Travis, 2003). 
While no significant changes were discovered in patients’ quality of life following 
gastrostomy, caregivers reported significantly greater levels of caregiver strain. Authors 
concluded that the observed increase in caregiver strain may be explained by the 
progressive nature of ALS. The motor disability of patients continues to increase due to 
gradual denervation of motor neurons, increasing their physical dependence on the 
caregiver. Additionally, authors did not offer statistical comparisons between caregiver 
strain and disease-related patient factors pre- and post-gastrostomy. It should also be 
noted that patient-caregiver dyads were enrolled as study participants only after agreeing 
to proceed with gastrostomy insertion. These aspects of the study confound the 
conclusion that can be made as to the factors related to increased caregiver strain 
following gastrostomy insertion.  
The hypothesis that gastrostomy improves quality of life in caregivers by 
reducing caregiver burden has yet to be rigorously tested in a large, prospective study. 
Furthermore, studies with documented levels of increased caregiver burden following 
gastrostomy in patients with ALS have yet to be replicated. The current study would take 
up this task with respect to gastrostomy intervention and its impact on caregiver strain as 
an index of quality of life in caregivers of patients with ALS. Global or health-related 
quality of life instruments may not be sensitive to the specific changes in caregiver 
quality of life as impacted by gastrostomy, relative to caregiver burden. To understand 
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the specific factors that impact a caregiver’s quality of life, investigators must employ 
instruments that are sensitive to these factors (Simmons, 2015).  
Research Hypotheses 
1. Following gastrostomy, caregiver strain, as indexed by scores on the Modified 
Caregiver Strain Index (MCSI), will decrease when compared to levels of 
caregiver strain prior to gastrostomy. 
2. Caregiver strain will be positively correlated with the severity of the patient’s 
functional impairments due to disease progression, as indexed by scores on the 
Amyotrophic Lateral Sclerosis Functional Rating Scale Revised (ALSFRS-R). 
3. Prior to gastrostomy, caregiver strain will be positively correlated with the 
severity of the patient’s self-reported symptoms of dysphagia, as indexed by 
scores on the Eating Assessment Tool (EAT-10). Increased severity of the 
patient’s dysphagia will be associated with increased levels of caregiver strain. 
4. Prior to gastrostomy, caregiver strain will be negatively correlated with patient-
reported swallowing-related quality of life, as indexed by scores on the 
Swallowing Quality of Life Questionnaire (SWAL-QOL). Decreased swallowing-
related quality of life in patients will be associated with increased levels of 
caregiver strain. 
Chapter Summary 
Chapter 2 reviewed the current literature on quality of life in caregivers, including 
individuals diagnosed with ALS and/or dysphagia, and the small amount of available 
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research on the impact of gastrostomy on caregiver quality of life. Chapter 3 outlines the 
methodology of the study. 
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Chapter Three:  Methodology 
The study was conducted within the University of Kentucky ALS 
Multidisciplinary Clinic, located at the Kentucky Neuroscience Institute. The Institutional 
Review Board (IRB) at the University of Kentucky (UK) approved participant 
recruitment and survey administration procedures.  
Design 
The study’s observational, prospective, longitudinal design examined how 
gastrostomy impacts self-reported levels of caregiver strain in caregivers of patients 
diagnosed with ALS and neurogenic dysphagia. There are understandable ethical 
limitations of withholding a medical intervention; thus, patients and caregivers who met 
the inclusion criteria were recruited regardless of their decision to accept or decline 
gastrostomy in the future. Patients and their caregivers were enrolled in the study and 
followed throughout the disease progression, potentially in the presence of worsening 
dysphagic symptoms and the impending decision of whether to accept or decline 
gastrostomy.  
Patients were blinded to the survey responses of caregivers. Due to impaired limb 
mobility, some patients were unable to complete their surveys independently outside of 
clinic and had to rely on caregivers for assistance to complete the surveys. In this case, a 
caregiver was not blinded to the survey responses of the patient. Research personnel 
anticipated if a patient required assistance to complete surveys and instructed caregivers 
to not influence the patient’s survey responses.  
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Participants 
A total of 26 participants, or 13 patient-caregiver dyads, were recruited to 
participate in the study from June 2018 to March 2019. To date, one patient-caregiver 
dyad completed surveys during both phases of the study— prior to gastrostomy and 
following gastrostomy. The results of this patient-caregiver dyad were presented as a 
single case study, with further results from other dyads pending.  
Patient-caregiver dyads were recruited from a convenience sample of patients 
who were diagnosed with ALS and receiving healthcare services through the UK ALS 
Multidisciplinary Clinic. A patient and their caregiver were enrolled in the study together 
as a dyad; hence both the patient and caregiver were required to meet specific inclusion 
criteria. Patients were eligible to participate in the study based on the following five 
inclusion criteria: (1) diagnosis of ALS, (2) presence of bulbar symptoms, (3) 
consumption of an oral diet with no alternative means of nutrition, (4) no evidence of 
cognitive impairment, and (5) reliance on an informal caregiver for care and assistance 
(see Appendix A). For the first inclusion criterion, patient must have a diagnosis of ALS 
as defined by the revised El-Escorial diagnostic criteria (Brooks, Miller, Swash, & 
Munsat, 2000). Regarding the second criterion, the presence and severity of bulbar 
symptoms were evaluated by the neurologist and documented using the revised 
questionnaire-based ALS Functional Rating Scale (ALSFRS-R, Cedarbaum et al., 1999). 
Within the ALSFRS-R, the domain of bulbar functions encompasses three component 
scales: speech, salivation, and swallowing. Bulbar symptoms were considered present if a 
patient received a score of less than 4 on any of the three bulbar component scales. The 
third criterion for inclusion in this study specified the requirement for the patient to be 
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currently consuming an oral diet and not engaging in non-oral means of nutrition, i.e., the 
patient cannot already have a gastrostomy tube in place. The fourth inclusion criterion 
was based on the discretion of research personnel, and patient-caregiver dyads were 
excluded if the patient and/or caregiver exhibited overt cognitive impairment or appeared 
too unwell to participate in the study. The fifth and final inclusion criterion for the patient 
to participate in the study coincided with the single inclusion criterion for the caregiver—
a caregiver was eligible to participate in the study if they were an adult individual (at 
least 18 years of age) who provided unpaid care and assistance to the patient with ALS. If 
the patient reported relying on multiple caregivers, the primary caregiver, as indicated by 
the most time devoted to care and assistance, was recruited to participate. Formal 
caregivers, defined as adult individuals who performed caregiving duties for monetary 
reimbursement, were excluded from the study.  
Patient-caregiver dyads who met the above inclusion criteria were invited to 
participate in the study during their regularly scheduled clinic visit at the UK ALS 
Multidisciplinary Clinic. Informed consent was obtained from patients and caregivers 
who agreed to participate by signing consent forms approved by the UK IRB (see 
Appendix B). Participants were briefed on the purpose of the study, estimated time 
commitment to complete surveys, expected timeline of the study, deidentification and 
storage of survey responses, and their rights as participants in the study. Randomized 
study participant numbers were assigned to patient-caregiver dyads to deidentify the 
survey response data, and to link the survey response data within each dyad. Electronic 
data, including participant email addresses, clinical and demographic data, and survey 
responses, were stored within a database in REDCap, a secure online web application. 
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Physical forms associated with the study, including signed informed consent forms and 
paper survey responses, were filed in a locked office within the College of Health 
Sciences at the University of Kentucky. 
Instrumentation 
Since the purpose of this study was to evaluate the impact of gastrostomy on 
quality of life in caregivers of patients with ALS and neurogenic dysphagia, the focus 
was on the caregiver responses. Caregivers completed the Modified Caregiver Strain 
Index (MCSI, see Appendix C) to assess self-reported levels of caregiver strain as an 
index of quality of life (Thornton & Travis, 2003). The MCSI is a 13-item tool used to 
assess the subjective and objective determinants of caregiver strain across physical, 
financial, emotional, and social/personal domains. Responses for each survey item are 
quantified by the frequency of occurrence: 0 points for ‘no’, 1 point for ‘yes, sometimes’, 
and 2 points for ‘yes, regularly’. Higher levels of caregiver strain are indicated by higher 
scores on the MCSI, with the total score ranging from 0 to 26. The MCSI represents a 
stable and reliable measure of caregiver strain over time, and increased caregiver strain 
has been associated with reduced quality of life in caregivers of patients with ALS, 
stroke, and other chronic disabilities (Burke et al., 2017; Litzelman et al., 2015). 
Additionally, the selection of the MCSI allowed cross-study comparisons with similar 
investigations into the impact of gastrostomy on caregiver quality of life (ProGas Study 
Group, 2015). 
The Eating Assessment Tool (EAT-10, see Appendix D) is a 10-item symptom-
specific screening tool used to assess the presence and severity of dysphagia (Belafsky et 
al., 2008). Dysphagic symptoms are rated using a 5-point scale ranging from 0 (no 
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problem) to 4 (severe problem), and the total score is calculated as a sum of all 10 items. 
The EAT-10 has been documented as a valid and reliable instrument to predict aspiration 
risk in patients diagnosed with ALS (Plowman et al., 2016). Patients who receive a total 
score of greater than 3 on the EAT-10 are at risk for unsafe airway protection and are 
twice as likely to experience penetration or aspiration while swallowing. Levels of 
caregiver strain are potentially impacted by the caregiver’s perceptions of the patient’s 
dysphagic symptoms and severity, as indexed by the EAT-10. Additionally, based on 
clinical experience, patients and caregivers have been observed to disagree on the degree 
of swallowing impairment. Both patient and caregiver were instructed to complete the 
EAT-10 to determine whether a concordance exists between patient’s ratings of their 
swallowing impairment and the caregiver’s ratings of the swallowing impairment, to 
assess the relationship between caregiver strain and caregiver’s perceptions of the 
patient’s swallowing impairment, and to evaluate how these perceptions of swallowing 
impairment may correlate to caregiver strain following gastrostomy. 
The Swallowing-Related Quality of Life instrument (SWAL-QOL, see Appendix 
E) was administered to evaluate the patient’s perception of how their dysphagic 
symptoms impact their quality of life and whether swallowing-related quality of life 
changes following gastrostomy (McHorney, Martin-Harris, Robbins, & Rosenbek, 2006; 
McHorney et al., 2002). The SWAL-QOL contains 44 survey items covering 11 domains 
of quality of life surrounding the meal experience that are potentially impacted by 
dysphagia. Swallowing-related quality of life domains include burden of dysphagia, 
eating desire, eating duration, food selection, communication, fear related to swallowing, 
mental health, social concerns related to swallowing, fatigue, sleep, and dysphagia 
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symptom frequency. Patients rate survey items using a 5-point Likert scale, with 1 
indicating high frequency (very much true, almost always, strongly agree, all of the time, 
always true) and 5 indicating low frequency (not at all true, never, strongly disagree, 
none of the time, never true). A total SWAL-QOL score is derived ranging from 0 to 100, 
with higher scores representing higher ratings of quality of life related to swallowing. The 
SWAL-QOL questionnaire ends with options to indicate the currently consumed diet 
texture and liquid consistency and evaluate the patient’s perception of their overall 
health: poor, fair, good, very good, or excellent. In patients diagnosed with ALS, lower 
SWAL-QOL scores were significantly correlated with increased dysphagia severity and 
the instrument differentiates patients who are safely swallowing versus patient who are 
more likely to experience unsafe swallowing (penetration versus aspiration) (Paris et al., 
2013; Tabor et al., 2016).  
Survey Procedure 
Participants completed surveys during two phases of the study: pre-gastrostomy 
and post-gastrostomy. To reduce the time burden associated with completing surveys, 
participants were offered the option to complete surveys via mail or online. Within the 
REDCap database, an electronic link was generated and sent to the participant’s email 
address. When clicked, the electronic link opened a webpage that presented surveys 
sequentially, with responses required for all survey items before the participant was 
allowed to proceed to the next survey. As a matter of convenience, participants were able 
to complete their set of online surveys across multiple sessions, if necessary. The 
electronic link maintained the participant’s progress through the surveys. If the 
participant did not have reliable internet and/or email access or the participant preferred 
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to complete the set of surveys on paper, physical copies of surveys were provided. Each 
set of surveys contained a cover page (to maintain privacy of survey responses and to 
clearly distinguish whether the set of surveys was for the patient or the caregiver), the 
study participant identification number, and a stamped envelope addressed to the UK 
ALS Multidisciplinary Clinic.  
Pre-Gastrostomy Phase. Participants within each patient-caregiver dyad 
completed surveys at or around each regularly scheduled visit, beginning with the clinic 
visit during which informed consent was obtained. At the UK ALS Multidisciplinary 
Clinic, patients were routinely scheduled for clinic visits once every 3 months. 
Accordingly, each patient-caregiver dyad completed surveys at intervals of 
approximately 3 months. Participants completed surveys during or following the clinic 
visit. If surveys were not completed within 1-2 weeks of the clinic appointment, 
participants were contacted and reminded to complete the surveys. Research personnel 
estimated surveys required between 20-30 minutes to complete. 
The number of clinic visits a patient attends prior to electing to proceed with 
gastrostomy varies; however, due to the rapid disease progression and negative 
prognostic value of malnutrition and weight loss observed in patients exhibiting bulbar 
symptoms, patients typically attend three clinic visits prior to proceeding with 
gastrostomy tube insertion. Patient-caregiver dyads completed surveys at 3-month 
intervals until the patient elected to proceed with gastrostomy, or, in the case of declining 
gastrostomy, until the patient was no longer consuming an oral diet. 
Post-Gastrostomy Phase. At the UK ALS Multidisciplinary Clinic, gastrostomy 
was offered based on the practical guidelines disseminated by the AAN (Miller et al., 2009; 
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Miller et al., 1999). Gastrostomy was recommended to patients in the presence of 
symptomatic dysphagia as indicated by self-reported symptoms during clinical interview, 
weight loss greater than 10% from stated usual adult body weight, inability to meet 
nutritional needs, or forced vital capacity (FVC) measured at 50% of predicted value. It is 
recommended that patients who wish to proceed with gastrostomy do so before their FVC 
dips below 50% of predicted value to reduce the risk of surgical complications. Eight weeks 
following the procedure, patient-caregiver dyads completed a final set of surveys. The 
choice to reassess caregiver strain at 8 weeks post-gastrostomy was a pragmatic decision, 
so as to allow for any potential influence of gastrostomy on levels of caregiver strain.  
Outcome Measures 
The primary outcome measure of the study was self-reported levels of caregiver 
strain, as indexed by the MCSI. Caregivers completed the MCSI on at least one timepoint 
prior to gastrostomy and at a single timepoint following gastrostomy.  
Secondary outcome measures included caregiver perceptions of swallowing 
impairment and patient perceptions of swallowing impairment, as indexed by the EAT-
10. Swallowing-related quality of life was evaluated by the patient using the SWAL-
QOL. Perceptions of swallowing impairment and swallowing-related quality of life were 
collected on at least one timepoint prior to gastrostomy and at a single timepoint 
following gastrostomy. Other secondary outcome measures included patient clinical data 
collected at each clinic visit to assess disease progression and functional changes in 
impairment. Clinical data included weight (kilograms), body mass index, and forced vital 
capacity. The ALSFRS-R was used to track functional changes in changes in bulbar-
specific symptoms and overall disease progression (Cedarbaum et al., 1999). Twelve 
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questions encompassing common tasks of daily living were rated by the neurologist on a 
5-point scale, with a score of 0 indicating no function (inability) and a score of 4 
indicating full function (normal ability). The selected tasks involved bulbar function 
(speech, salivation, swallowing), limb function (handwriting, cutting food, dressing and 
hygiene, turning in bed, walking, climbing stairs), and respiratory function (dyspnea, 
orthopnea, respiratory insufficiency). Scores for each of the 12 tasks are summed to 
produce a total score, ranging from 0 to 48. A lower total score on the ALSFRS-R 
suggests a greater degree of functional impairment. Total scores on the ALSFRS-R 
demonstrate strong correlations with objective measures of muscular and pulmonary 
functioning, and the progression of scores on the ALSFRS-R are significantly related to 
prognosis (Ruoppolo et al., 2013).  
Chapter Summary 
Chapter 3 served to outline the methodology employed to assess the relationship 
between caregiver strain and dysphagia severity both before and after gastrostomy. 
Chapter 4 presents the results of the study. 
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Chapter Four:  Results 
Participants 
A total of 26 participants, or 13 patient-caregiver dyads, were recruited to 
participate in the study from a convenience sample of patients who were diagnosed with 
ALS and receiving healthcare services through the UK ALS Multidisciplinary Clinic. To 
date, eight dyads were withdrawn from the study, as indicated in Figure 4.1. Five dyads 
completed, or are currently completing, surveys during the pre-gastrostomy phase of the 
study. Of these five dyads, one dyad completed surveys during both the pre-gastrostomy 
and post-gastrostomy phases of the study, and the results of this patient-caregiver dyad 
are presented as a single case study below. 
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Figure 4.1:  Profile of Participant Recruitment and Enrollment 
 
 
 
 
 
 
 
 
 
 
 
 
5 dyads enrolled in pre-gastrostomy 
phase 
2 dyads withdrawn voluntarily 
1 dyad withdrawn due to proceeding with 
gastrostomy prior to returning pre-
gastrostomy surveys 
2 dyads withdrawn due to hospice or death 
3 dyads withdrawn due to no response 
13 patient-caregiver dyads recruited and 
consented to participate in study 
1 dyad completed pre-gastrostomy 
phase and post-gastrostomy phase 
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Dyad Characteristics 
The patient is a white male, age 75 years, and the informal caregiver is his female 
spouse. The patient is a retired healthcare professional and previously worked in mental 
health services. He reportedly was diagnosed in October 2018 after experiencing 
symptoms for 1 year, and his first clinic visit followed shortly thereafter. Participants 
consented to participate during their first clinic visit and completed pre-gastrostomy 
surveys via mail immediately following the clinic visit. The patient completed all pre-
gastrostomy surveys: the EAT-10 and SWAL-QOL. However, the caregiver completed 
only the MCSI both pre- and post-gastrostomy. She did not complete the EAT-10 during 
the pre-gastrostomy phase. Research personnel attempted to follow-up multiple times; 
however, she was unable to complete and return the survey before the patient proceeded 
with gastrostomy. Thus, comparisons between patient and caregiver perceptions of the 
patient’s swallowing impairments were not possible. The patient underwent gastrostomy 
tube insertion in December 2018. The patient and caregiver completed all surveys during 
the post-gastrostomy phase in January 2019.  
Outcome Measures 
Primary outcome measure. The primary purpose of this study was to assess the 
self-reported levels of caregiver strain at two time points: (1) before gastrostomy, when 
the patient was experiencing dysphagia and consuming an oral diet, and (2) after the 
patient proceeded with gastrostomy tube insertion. The caregiver completed the MCSI 
during both phases of the study, and the findings are reported in Table 4.1. The MCSI 
contains 13 items, with a total score ranging from 0 (no caregiver strain) to 26 (highest 
caregiver strain). The caregiver self-reported a caregiver strain score of 2 during the pre-
36 
 
gastrostomy phase, and caregiver strain increased to 9 during the post-gastrostomy phase. 
Though the MCSI contains a total of 13 items, the caregiver’s responses to 7 items were 
listed in Table 4.1 to elucidate any changes in her self-reported levels of caregiver strain 
between the pre-gastrostomy phase and the post-gastrostomy phase. The caregiver 
supplemented some of her survey responses on the post-gastrostomy survey with 
qualitative information. For the survey item ‘There have been emotional adjustments’, 
the caregiver wrote, “No arguments. My emotions are like a roller coaster.” After the 
caregiver answered “yes, sometimes” to the survey item ‘It is upsetting to find the person 
I care for has changed so much from his/her former self’, she wrote, “Very different 
physically, he continues to be very awesome.” 
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Table 4.1  Primary Outcome Measure: Caregiver Strain 
 Pre-Gastrostomy Post-Gastrostomy 
MCSI, Total 2 9 
My sleep is disturbed. No Yes, Sometimes 
There have been family 
adjustments. 
No Yes, Sometimes 
There have been changes 
in personal plans. 
No Yes, Sometimes 
There have been other 
demands on my time. 
No Yes, Sometimes 
There have been 
emotional adjustments. 
No 
Yes, On a regular basis 
“No arguments. My emotions are 
like a roller coaster.” 
It is upsetting to find the 
person I care for has 
changed so much from 
his/her former self. 
No 
Yes, Sometimes 
“Very different physically, he 
continues to be very awesome.” 
I feel completely 
overwhelmed. 
Yes, On a 
regular basis 
Yes, On a regular basis 
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Secondary outcome measures. The study assessed multiple secondary outcome 
measures to further elucidate the relationship between caregiver strain, dysphagia, patient 
swallowing-related quality of life, gastrostomy, and disease progression. Secondary 
outcome measures were assessed prior to gastrostomy and following gastrostomy and 
included patient’s perception of his dysphagia severity (EAT-10), patient’s ratings of his 
swallowing-related quality of life (SWAL-QOL), functional impairments due to disease 
progression (ALSFRS-R, Total), bulbar function due to disease progression (ALSFRS-R, 
Bulbar), weight (kilograms), body mass index, and forced vital capacity. Table 4.2 
displays the patient’s perception of his swallowing impairment (EAT-10). The patient’s 
EAT-10 score was rated 34 (out of a total of 40) when he was consuming an oral diet and 
not relying on alternative means of nutrition (pre-gastrostomy phase). Following 
gastrostomy tube insertion, his EAT-10 scores increased to 36, suggesting he perceived 
his swallowing impairment to have increased following gastrostomy. 
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Table 4.2  Secondary Outcome Measure: Patient Dysphagia Severity 
 Pre-Gastrostomy Post-Gastrostomy 
EAT-10, Total 34 36 
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The patient completed the SWAL-QOL before and after gastrostomy and Table 
4.3 displays the results. The patient’s total score on the SWAL-QOL decreased from 53.5 
to 48.5 following gastrostomy, consistent with a reduction in the patient’s overall 
swallowing-related quality of life. Decreased ratings of quality of life were observed in 
the domains of the burden of dysphagia, eating desire, eating duration, food selection, 
communication, fear, and dysphagia symptoms. The largest decline in swallowing-related 
quality of life scores from pre-gastrostomy to post-gastrostomy was within the domain of 
eating desire, with the patient indicating he cares less about eating, he is rarely hungry, 
and he no longer enjoys eating. Changes in the patient’s survey responses within the 
domain of fear included increased fear of choking when eating and drinking but 
improvements in his perception of knowing when he might choke. 
Following gastrostomy, the patient reported improvements in the four quality of 
life domains: mental health related to swallowing, social concerns related to swallowing, 
fatigue, and sleep. The largest improvement in scores from pre-gastrostomy to post-
gastrostomy was within the domain of fatigue, with the patient reporting less weakness, 
tiredness, and exhaustion. Of note were the changes within the domains of mental health 
and social functioning. Regarding mental health related to swallowing, the patient 
reported slight reduction in the frequency of depression, annoyance, discouragement, and 
impatience regarding his swallowing problem and a slight increase in his frustration with 
his swallowing problem. In the domain of social concerns regarding his swallowing 
problem, the patient reported slight reduction in work/leisure changes, and a larger 
reduction in role changes with family and friends. 
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Table 4.3  Secondary Outcome Measure: Patient Swallowing-Related Quality of Life 
 Pre-Gastrostomy Post-Gastrostomy 
SWAL-QOL, Total 53.5 48.5 
SWAL-QOL, Burden 30 20 
SWAL-QOL, Eating Desire 60 26.7 
SWAL-QOL, Eating Duration 30 20 
SWAL-QOL, Food Selection 50 30 
SWAL-QOL, Communication 40 20 
SWAL-QOL, Fear 70 60 
SWAL-QOL, Mental Health 60 72 
SWAL-QOL, Social Concerns 48 60 
SWAL-QOL, Fatigue 66.7 86.7 
SWAL-QOL, Sleep 80 90 
SWAL-QOL, Symptoms 55.7 42.9 
SWAL-QOL, Diet Texture Soft, easy to chew foods 
like casseroles, canned 
fruits, soft cooked 
vegetables, ground meat, 
or cream soups. 
All nourishment 
through a tube. 
SWAL-QOL, Liquid Consistency Liquids such as water, 
milk, tea, fruit juice, and 
coffee. 
No liquids by mouth or 
limited to ice chips. 
SWAL-QOL, Overall Health Fair Fair 
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Table 4.4 presents the patient clinical data during both phases of the study: pre-
gastrostomy and post-gastrostomy. The patient’s total scores on the ALSFRS-R increased 
from 32 to 35 following gastrostomy. Bulbar function on the ALSFRS-R was rated as 5 
during the pre-gastrostomy phase and decreased to 4 during the post-gastrostomy phase. 
The decline in bulbar function was documented as a reduction in the patient’s verbal 
speech ability. The patient’s weight and body mass index increased following 
gastrostomy, from 82.1 kilograms to 83.9 kilograms and 26.7 to 27.4, respectively. 
Forced vital capacity decreased following gastrostomy from 70% to 60%.  
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Table 4.4  Secondary Outcome Measures: Patient Clinical Data 
 Pre-Gastrostomy Post-Gastrostomy 
ALSFRS-R, Total 32 35 
ALSFRS-R, Bulbar 5 4 
Weight (kilograms) 82.1kg 83.9kg 
Body Mass Index 26.7 27.4 
Forced Vital Capacity (%) 70% 60% 
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Summary of outcome measures. One primary outcome measure and eight 
secondary outcome measures were assessed at two time points: pre-gastrostomy and post-
gastrostomy. The caregiver reported increased levels of caregiver strain following 
gastrostomy. The patient reported increased severity of swallowing impairment, 
decreased swallowing-related quality of life, improved overall functional impairment, 
reduced bulbar function, increased weight and body mass index, and decreased forced 
vital capacity following gastrostomy. 
Chapter Summary 
Chapter 4 presented a case study of a single patient-caregiver dyad prior to and 
following gastrostomy. The fifth and final chapter provides a discussion of results, 
limitations of the study, and implications for future research.  
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Chapter Five:  Discussion 
Review of Purpose 
Informed, autonomous consent is a necessary part of the decision to proceed with 
gastrostomy, and it is the onus of healthcare professionals to provide a clear explanation 
of the benefits and burdens of gastrostomy (DeLegge et al., 2005). There is little research 
studying the nature of the relationship between caregiver quality of life and palliative 
interventions that manage dysphagia in patients diagnosed with ALS (Katzberg & 
Benatar, 2011). A medical intervention that increases caregiver strain may decrease the 
effectiveness of the care they provide to the patient and ultimately result in a cascade of 
negative ramifications for both the patient and caregiver. To facilitate a comprehensive 
assessment of treatment effectiveness, and better guide patients and their families in their 
decision to proceed or decline gastrostomy, this study aimed to investigate the 
relationship between gastrostomy and caregiver strain as an index of quality of life in 
caregivers of patients with ALS and dysphagia. Secondary outcome measures were 
explored to evaluate the associations between caregiver strain and patient-specific factors 
such as swallowing-related quality of life, severity of dysphagia, and disease progression. 
Review of Methodology 
Thirteen patient-caregiver dyads were recruited to participate in the prospective, 
observational, longitudinal study. Patients and their informal caregivers were recruited to 
participate in the study prior to their decision regarding whether to accept or decline 
gastrostomy. To date, one patient-caregiver dyad completed surveys during both the pre- 
and post-gastrostomy phase. There were two phases of the study: pre-gastrostomy phase 
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and post-gastrostomy phase. Both patients and caregivers completed surveys at one or 
more time points, roughly every 3 months, during the pre-gastrostomy phase. Once the 
patient proceeded with gastrostomy, both the patient and the caregiver completed a final 
set of surveys. 
The primary focus of the study was on the caregiver responses. To assess 
caregiver strain, caregivers completed the MCSI. Severity of the patient’s dysphagia was 
assessed using the EAT-10, and both caregivers and patients rated their perceptions of the 
patient’s swallowing impairment. The SWAL-QOL was employed to assess the patient’s 
swallowing-related quality of life. The patient’s overall disease-specific impairment and 
bulbar dysfunction was rated by the neurologist at each clinic visit using the ALSFRS-R. 
Clinical data, including weight, body mass index, and forced vital capacity, was collected 
to assess disease progression. 
Discussion of Results 
The study proposed four hypotheses. The first hypothesis, that caregiver strain 
would decrease following gastrostomy, was not supported. The second hypothesis 
proposed a positive relationship between caregiver strain and degree of the patient’s 
functional impairment. This hypothesis was partially refuted: caregiver strain increased 
as the patient’s overall function improved or stabilized. However, a decline was observed 
in the patient’s bulbar function, specifically in the domain of speech. The third and fourth 
hypotheses compared levels of caregiver strain, severity of the patient’s dysphagia, and 
the patient’s swallowing-related quality of life. These final hypotheses could not be 
evaluated since outcome measures for this single patient-caregiver dyad were assessed at 
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a single time-point during the pre-gastrotomy phase. Thus, no comparisons could be 
made either within participants or between participants.  
Caregiver strain. The single case study design prevented generalizing results to 
the wider population of caregivers of patients with ALS. Despite this limitation, some 
comments can be made regarding the increase in caregiver strain observed within this 
patient-caregiver dyad following gastrostomy. The hypothesis of this study was not 
supported in that the caregiver reported a higher level of self-perceived caregiver strain 
following gastrostomy, whereby the total MCSI score increased from 2 (pre-gastrostomy) 
to 9 (post-gastrostomy). The MCSI does not categorize scores to differentiate between 
clinically significant levels of caregiver strain; accordingly, it was difficult to conclude 
that meaningful change has occurred between levels of caregiver strain for this individual 
caregiver relative to gastrostomy. The ProGas Study Group previously investigated the 
relationship between gastrostomy and caregiver strain as indexed by the MCSI and 
discovered that caregiver strain significantly increased following gastrostomy placement 
(mean [SD] total MCSI score 9.9 [6.4] at baseline versus 11.8 [6.5] at 3 months; p=0.01) 
(ProGas Study Group, 2015). The caregiver participating in the current study reported 
comparatively less caregiver strain before and after gastrostomy. However, statistical 
analyses were not performed.  
Additionally, for this particular patient-caregiver dyad, the pre-gastrostomy 
survey was completed following their first clinic visit when the patient’s diagnosis was 
relatively recent. This may explain the caregiver’s low total MCSI score during the pre-
gastrostomy phase. The patient proceeded with gastrostomy tube insertion shortly 
thereafter due to the severity of dysphagia, difficulty maintaining adequate nutrition and 
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hydration, and declining forced vital capacity. While there were no dramatic changes in 
the patient’s disease-specific impairments as detected by the ALSFRS-R in the time 
period between the pre-gastrostomy surveys and the post-gastrostomy surveys, the 
patient’s speech was noted to have declined. In the presence of multiple confounding 
variables, it remains unclear what factor was most influential in the increase of caregiver 
strain post-gastrostomy: responsibilities involved in the use and maintenance the 
gastrostomy tube, the slight worsening of the patient’s verbal speech, the chronic 
presence of dysphagia, the psychological distress of coping with a terminal illness, or a 
myriad of factors. 
Gastrostomy is recommended as a symptomatic management of malnutrition and 
weight loss; however, the placement of a gastrostomy tube does not ameliorate bulbar 
symptoms. A gastrostomy tube will not return the pleasurable and social aspects of 
sharing a meal with others, as evidenced by the reduction in the patient’s swallowing-
related quality of life post-gastrostomy. Although patients are encouraged to continue 
oral intake as tolerated, the patient within the present case study reportedly ceased oral 
intake of food and liquid due to dysphagia severity. Previous literature called attention to 
caregiver reports of feelings of guilt when eating in front of the patient and engaging in 
an activity they once shared, while patients reported reluctance to stay in the same room 
when others were eating (Stavroulakis et al., 2016). The patient in this study continued to 
experience worsening verbal communication due to dysarthria, and previous studies have 
demonstrated the relative importance of loss of speech and mobility restrictions over 
swallowing impairments (Chio et al., 2005; Hecht et al., 2002). Multiple longitudinal 
studies documented stabilization in patient quality of life and a significant increase in 
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caregiver strain and burden over time (Creemers et al., 2014; Gauthier et al., 2007; 
ProGas Study Group, 2015). If gastrostomy acts to alleviate or increase the degree of 
caregiver strain in caregivers responsible for dysphagia management, the change may not 
be readily discernible, and may not alleviate the potentially devastating social, cultural, 
and psychological impacts of progressively worsening symptoms on quality of life in 
patients with ALS and their caregivers. 
The literature on caregiver strain, burden, and quality of life is often restricted in 
scientific rigor owing to cross-study inconsistencies in operational definitions, 
instruments, and findings (Cousins et al., 2002). A conceptual analysis of caregiver 
burden identified the characteristics of the caregiver, the demands of caregiving, and the 
involvement in caregiving as predisposing factors to caregiver burden, i.e., factors that 
may increase the risk of experiencing caregiver burden (Chou, 2000). Due to the 
heterogeneity in the presentation and progression of ALS, some authors suggest that self-
reported levels of caregiver burden reflect relative constancy throughout disease 
progression and that any reported fluctuations in caregiver burden are consistent with 
characterological differences among patient-caregiver dyads (Burke et al., 2018). Without 
a pre-morbid assessment of personality types, interpersonal dynamics, coping styles, and 
the potential effects of providing care in the presence of a terminal diagnosis, such 
characterological differences remain confounding variables that limit what conclusions 
can be drawn from the association between caregiver strain and gastrostomy in the 
framework of a terminal illness. Regardless, continued investigation into the impact of 
gastrostomy on caregiver strain are needed such that these limitations do not result from a 
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dearth of investigation but rather the limits of what clinical research in this field can 
definitively establish.  
Further, it is unclear whether the current study places undue emphasis on 
dysphagia as a disability instead of focusing on what is most important for the particular 
patient and caregiver in the course of the disease progression. Previous studies suggest 
caregiver strain does not correlate with the patient’s disease-specific variables but, rather, 
is correlated with intrinsic factors of the caregiver, the care recipient, and their dyadic 
relationship (Burke et al., 2018; Simmons et al., 2000). On the MCSI survey item 
regarding emotional adjustments, the caregiver provided an addendum, “no arguments, 
my emotions are like a roller coaster.” Previous literature documented significant 
associations between increased caregiver burden, lower quality of life, and higher levels 
of distress, anxiety, and depression (Burke et al., 2017). In this study, the authors 
speculated that the observed reduction in a caregiver’s quality of life and increased levels 
of self-reported caregiver burden were primarily influenced by the subjective experience 
of the caregiver, including the caregiver’s resiliency, coping-styles, pre-morbid 
personality characteristics, and the extent of and reliance on support networks. In a study 
on caregivers of neurological patients with dysphagia, authors found correlations between 
the anxiety level of caregivers and the presence of dysphagia, but caregiver anxiety did 
not correlate with any patient-related factors, including the severity of dysphagia, the 
duration of dysphagia, the condition of a patient’s dependency on the caregiver for eating 
and drinking, and the reliance on gastrostomy (Serel Arslan et al., 2017). Medical 
interventions aimed at managing dysphagia, such as gastrostomy, may not have a 
predictable impact on caregiver strain. Other psychosocial factors within a given patient-
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caregiver dyad may be stronger predictors of caregiver strain, burden, and quality of life 
in caregivers of patients diagnosed with ALS. 
Some studies found that caregiver quality of life may be modified or mediated by 
the degree of perceived social support more than physical limitations of the disease 
(Chou, 2000; Simmons et al., 2000). In the current study, no insight was obtained 
regarding the type or intensity of caregiving duties, the amount of time devoted to 
caregiving per day, the total duration spent in the role of an informal caregiver, or the 
ancillary employment of formal caregiving assistance. Based on clinical anecdotes, 
patients with increased dependency on a caregiver for eating and drinking are more 
demanding than patients who are able to self-feed or prepare their own meals. Although 
Serel Arslan et al. (2017) did not find a significant association between caregiver anxiety 
and condition of patient dependency on caregiver for eating/drinking, the relationship 
warrants further investigation. All of these are relevant factors in the assessment of 
caregiver strain, and the MCSI may not have been sensitive to these variables. Currently, 
there is no ALS-specific scale of caregiver strain. To evaluate outcome data for a specific 
medical intervention such as gastrostomy, there is a need for more sophisticated measure 
of caregiver strain in this vulnerable population. 
Multidisciplinary Care. Multidisciplinary care for patients diagnosed with ALS 
is associated with positive treatment benefits, including increased duration of survival, 
reduced hospitalizations and mortality, and improved quality of life (Chio et al., 2006; 
Rosenfeld & Strong, 2015). As such, the sample of patients recruited to participate in the 
current study within the UK Multidisciplinary ALS Clinic may not be representative of 
other patients diagnosed with ALS and receiving their care elsewhere. Any conclusions 
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regarding the impact of gastrostomy on caregiver strain may not be generalizable to 
patients who are not enrolled in multidisciplinary care clinics. 
Withdrawal rates. Of the 13 patient-caregiver dyads recruited to participate in 
the study, one patient-caregiver dyad completed surveys during both phases of the study: 
pre-gastrostomy and post-gastrostomy (see Figure 4.1). Four patient-caregiver dyads are 
currently enrolled in the pre-gastrostomy phase of the study, having completed surveys 
on at least one occasion. Eight patient-caregiver dyads were withdrawn from the study 
due to no response, voluntary withdrawal, entering hospice, or death. Data collection for 
this study is ongoing at the UK Multidisciplinary ALS Clinic, and three sites located 
within the United States plan to join this investigation. The addition of external sites aims 
to increase participant recruitment to a total of 60 patient-caregiver dyads to improve 
statistical power and sample representativeness. 
Limitations 
Due to ethical considerations, randomized and controlled clinical trials may not be 
feasible in pursuing this line of prospective investigation. Although careful steps were 
taken to improve the scientific rigor of this observational study, there were numerous 
limitations characteristic of survey research. Self-selection bias, the process of a patient 
agreeing to participate in a study, introduces bias that may affect the survey responses 
(Heffernan et al., 2004). Clinical anecdotes suggested that patients may have 
underreported the severity of their swallowing problems, while caregivers may have 
underreported the burden of caregiving. In addition, there were challenges in scheduling 
the surveys. Research personnel attempted to obtain completed surveys as close to 3-
month intervals as possible but rescheduling of clinic appointments introduced variation 
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in the projected 3-month interval between visits to the UK ALS Multidisciplinary Clinic. 
Furthermore, occasional delays in survey completion occurred due to dyads misplacing 
paper copies of surveys, undelivered email surveys, and multiple reminders to complete 
survey responses.  
Missing data were observed due to participants omitting responses within surveys, 
research personnel’s inability to obtain all clinical data at every clinic visit, and concerns 
regarding the accuracy of forced vital capacity ratings in patients with severe bulbar 
symptoms. Conclusions regarding the relationship between levels of caregiver strain and 
the caregiver’s perception of the patient’s swallowing impairment were not possible as 
the caregiver did not complete all surveys during the pre-gastrostomy phase. Regarding 
the eight patient-caregiver dyads that were withdrawn from the study, this loss to follow-
up may have reduced the representativeness of the sample and lead to biased estimates 
(Thompson & Levy, 2004). The research personnel offered electronic and mail-based 
surveys to increase the response rate. However, the response rate within the sample of 
participants was low and this potentially hindered the overall longitudinal analysis 
(Messina & Beghi, 2012).  
Ample clinical discretion was exercised during the recruitment period. Though 
this was based on ethical considerations, this may have introduced a gate-keeping bias 
into the study (Aoun et al., 2012). Patients and their caregivers were excluded from 
participating in the study if they exhibited overt signs of cognitive impairment or if the 
symptomatology placed the patient in the end stages of ALS. Such exclusions of the more 
vulnerable patient-caregiver dyads may have represented an inadvertent selection bias. 
Although there was no formal screening or assessment of cognitive impairment, 
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participants were excluded from participating in the study if cognitive impairment was 
observed, whether diagnosed or clinically overt. Previous literature investigating quality 
of life in patients diagnosed with ALS and their caregivers is varied on the procedures for 
cognitive screening, with exclusion criteria ranging between clinical signs or symptoms,  
diagnoses of cognitive dysfunction, and brief cognitive screenings including the Montreal 
Cognitive Assessment (Creemers et al., 2014; Gauthier et al., 2007; Kurien et al., 2017). 
During the process of obtaining informed consent from participants, research 
personnel reviewed the identical consent forms with each patient-caregiver dyad; 
however, there was no standardization of this conversation. Research personnel attempted 
to introduce and explain the purpose of the study in a consistent manner, but it was not 
possible to have the same conversation with each dyad. Despite instructions during the 
recruitment process, and reminders during the consenting process that their participation 
in the study and/or responses on the surveys would not impact the level of care received 
at the clinic, participant responses may have been impacted. Research personnel also 
encouraged participants to complete the surveys independently and to avoid influencing 
any survey responses. Outside of clinic, however, patients and caregivers potentially 
completed surveys in the presence of their dyadic partner. 
Implications for Future Research 
While the focus of this study was on the caregiver responses, this study represents 
a section of a larger, more comprehensive investigation into the relationship between 
gastrostomy and quality of life of both patients and their caregivers. Longitudinal data is 
currently being collected on swallowing-related quality of life in patients prior to and 
following gastrostomy tube insertion and in patients who decline gastrostomy. Literature 
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differs as to whether patients with ALS who decline gastrostomy may serve as a 
comparator group to those patients who elect to receive gastrostomy, or whether causal 
inference models may be more suitable to avoid confounding by indication (McDonnell 
et al., 2017). As of January 2019, an IRB modification was completed to add a cross-
sectional component to the study to further elucidate the impact of disease-specific 
variables (bulbar symptoms versus limb symptoms). Patients without bulbar symptoms at 
their initial diagnosis were recruited to participate in the study to evaluate the impact of 
limb-onset symptoms on patient and caregiver quality of life and to investigate whether 
differences in self-reported caregiver strain exist between caregivers of patients with 
dysphagia and caregivers of patients without dysphagia. To further elucidate the impact 
of the dysphagia, gastrostomy, and disease-specific variables on emotional wellbeing of 
patients and caregivers, the Beck Anxiety Inventory and the Beck Depression Inventory 
were added to the battery of surveys (Bardhoshi, Duncan, & Erford, 2016; Beck, Steer, 
Ball, & Ranieri, 1996).  
Previous literature has accomplished qualitative explorations into the experiences 
of patients and caregivers regarding gastrostomy and caregiver strain (Stavroulakis et al., 
2016). During quantitative data collection of the current study, patients and their 
caregivers often volunteered unsolicited qualitative data along with their survey 
responses. These comments, next to their response on survey items, provided additional 
insight. In the future, this study will introduce a qualitative component to the current 
research design to encourage dialogue on the topic, obtain valuable opinions from 
patients and caregivers, and attempt to unpack the subjective phenomena behind 
changing levels of caregiver strain as it relates to gastrostomy. 
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Conclusions 
It is imperative to evaluate the strain placed on caregivers of patients diagnosed 
with ALS throughout disease progression. ALS is a progressive, terminal illness and the 
inevitable worsening of a patient’s impairments is likely to increase the physical and 
emotional demands placed on the caregiver. Caregivers who develop clinically 
significant levels of caregiver strain risk may become compromised in their physical 
and/or emotional health, which can, in turn, impact the care they provide to the patient. 
Medical recommendations and care provided within multidisciplinary clinics should 
consider interventions that address the well-being of caregivers in addition to patients 
(Boerner & Mock, 2012; Chio et al., 2005; Creemers et al., 2016). 
The decision to accept or decline gastrostomy must be guided by the preferences of 
the individual and their family, goals of treatment, and outcome data (DeLegge et al., 
2005). Healthcare professionals should provide clear, objective information of the 
anticipated benefits and burdens of gastrostomy (Squires, 2006). The ongoing 
investigation into the relationship between gastrostomy and quality of life in caregivers of 
patients diagnosed with ALS and dysphagia ultimately aims to contribute to the 
understanding of the treatment efficacy of gastrostomy to better guide patients and their 
families in their decision. 
Chapter Summary 
Chapter five discussed the results of this study, limitations, and implications for 
future clinical research.  
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Appendix A:  Study Manual 
Patients with ALS and Bulbar Symptoms 
 
1. Identify qualified patient and caregiver dyads: 
− Patient must meet all of the following criteria to qualify for the study: 
• Patient has a confirmed diagnosis of ALS. 
• Patient exhibits bulbar symptoms, as indexed by a score of < 4 on at 
least one of the bulbar subscales of the ALS Functional Rating Scale 
(ALS-FRS-R). These subscales are listed at the end of the manual. The 
ALS-FRS-R is also located at http://www.outcomes-
umassmed.org/als/alsscale.aspx 
• Patient does not have a PEG tube already in place. 
• Patient has an adult family member or friend who is considered the 
“primary caregiver” and they provide unpaid care and assistance. 
− New or current patients may be identified for qualification prior to or during 
the clinic appointment. 
• The research nurse or other study personnel may call the patient and/or 
caregiver at least 1 week prior to the clinic appointment to notify them 
of this study. 
• Interested patient/caregiver dyads may be asked to arrive 30 minutes 
prior to clinic appointment to meet with study personnel to further 
discuss the study and answer any questions. 
• Patient/caregiver dyads will be invited to participate in this study and 
asked to give consent to participate.  
• Patient/caregiver dyads will be consented in the clinic rooms during 
their appointments or in a separate consult room within the clinic.  
 
2. Consent patient/caregiver dyads. 
− Approved research personnel will consent patients and caregivers by 
reviewing the entire IRB consent form and having the participants sign and 
date the last page. 
• Participants will be provided copies of the signed IRB consent forms. 
− Research personnel should highlight the following: 
• Please complete the surveys independently. If the patient requires 
physical assistance with completing the survey, the caregiver may 
assist them. Caregivers should be encouraged to allow patients to 
answer questions without caregiver input.  
• It should take approximately 20-30 minutes to complete the set of 
surveys. 
• Patient and caregiver will complete surveys around the time of each 
follow-up clinic appointment (approximately every 3 months). 
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• Within the “Caregiver” set of surveys, the first survey (EAT-10) will 
ask a series of questions regarding swallowing. The caregiver needs to 
fill out the survey from the patient’s perspective. (Include a written 
reminder on the paper copy of the caregiver’s EAT-10.) 
− After consent forms have been completed, research personnel should politely 
request and document the caregiver’s age (years) and relationship to the 
patient. This information is stored in the caregiver demographics section in 
REDCap (see Step 3). 
 
3. Instruct & help participants complete the surveys. 
− Prior to survey administration: 
• Determine how the participants prefer to complete the surveys. 
▪ If the participants have reliable internet and email access, they 
may complete the surveys online.  
o Using The AWARE Study project in REDCap, an 
electronic link is generated and sent to the participant’s 
email address. When clicked, this link takes the 
participant to a webpage where they are able to 
complete the set of surveys. 
o It is preferred that the patient and caregiver have 
separate email accounts; however, it is possible to send 
both the “Patient” set of surveys and the “Caregiver” 
set of surveys to the same email address. Care must be 
taken to ensure that the caregiver completes the 
“Caregiver” set of surveys, and the patient completes 
the “Patient” set of surveys. Each set of surveys must 
be clearly labeled when sending the electronic link in 
REDCap. 
o It is possible for a participant to complete the online 
surveys in multiple sittings. If the participant exits the 
webpage without completing the set of surveys, they 
may click the electronic link within the email and a 
webpage will open that allows them to resume their 
survey progress. 
▪ If the participants do not have reliable internet and email access 
or the participants prefer to complete the surveys on paper, 
hard copies of surveys may be provided. 
o Include a cover page on each set of surveys to maintain 
privacy of survey responses. On the cover page, clearly 
label the set as either “Patient Surveys” or “Caregiver 
Surveys”. 
o Record the Participant ID on each set of surveys for 
identification purposes. 
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o If participants are completing the surveys outside of 
clinic, provide an appropriately sized envelope, stamps, 
and clinic mailing address. 
• Determine when the participants prefer to complete the surveys. 
▪ Participants may complete the surveys during the clinic 
appointment (via personal electronic device, paper copies, or 
clinic iPad). 
▪ Participants may complete the surveys outside of the clinic 
appointment (via personal electronic device or paper copies). 
− During survey administration: 
• Research personnel will send a link via REDCap or provide paper 
copies of the surveys. 
▪ Patients will complete the “Patient” set of surveys: 
o Eating Assessment Tool (EAT-10) 
o Swallowing Quality of Life Questionnaire (SWAL-
QOL) 
o Beck Anxiety Inventory (BAI) 
o Beck Depression Inventory (BDI)  
▪ Caregivers will complete the “Caregiver” set of surveys: 
o Eating Assessment Tool (EAT-10) 
o Modified Caregiver Strain Index MCSI) 
o Beck Anxiety Index (BAI) 
o Beck Depression Inventory (BDI) 
• Participants may complete the surveys during the clinic appointment 
or outside of clinic. 
▪ If participants are completing the surveys outside of clinic, 
research personnel will encourage the participants to complete 
the surveys independently and within 1 week of their clinic 
appointment.  
o If the patient requires physical assistance with 
completing the survey, the caregiver may assist them. 
Caregiver should be encouraged to allow the patient to 
answer questions without caregiver input.  
o Research personnel will call with a reminder to 
complete and submit the surveys after 1-2 weeks. 
▪ If participants are completing the surveys during clinic, 
research personnel should encourage the participants to 
complete the surveys independently. 
o Patients who require physical assistance to complete the 
surveys will receive assistance from research personnel 
as needed. 
o Caregivers may be offered a separate room in which to 
complete their set of surveys. Research personnel will 
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inform the caregiver of when a multidisciplinary team 
member is ready to see both of them for health services. 
The caregiver may then pause their survey progress to 
rejoin their family member for the appointment. The 
caregiver may return to complete the surveys at a later 
time. 
o Research personnel will be available to answer any 
questions or concerns. 
− Following survey administration: 
• Research personnel will collect paper copies of the completed surveys 
from the participant and transcribe the survey responses into REDCap. 
▪ Paper copies of completed surveys will be stored in CTW 
124K. 
• Research personnel will input demographic data for each patient and 
caregiver into the ‘Demographics’ portion of the study in REDCap.  
▪ Patient Demographics: 
o Gender 
o Age 
o Weight (kg) 
o Body Mass Index (BMI) 
o Total ALS Functional Rating Scale (ALS-FRS-R) 
o Bulbar Subsection on ALS-FRS-R 
o Forced Vital Capacity (FVC) 
o Current assistive equipment, e.g., Cough Assist, Non-
Invasive Ventilation, CPAP/BiPAP, AAC device(s), 
none. 
▪ Caregiver Demographics 
o Gender 
o Age 
o Caregiver relationship, e.g., spouse/partner, mother, 
father, sibling, child, friend, other. 
 
4. During subsequent clinic visits, patient/caregiver dyads will be asked to arrive 30 
minutes early in order to complete the surveys during the clinic appointment or the 
patient/caregiver dyads will be asked to complete the surveys outside of the clinic. 
The same process outlined above should be followed. 
 
5. This survey process will be repeated at each clinic visit leading up to PEG placement 
(if patient elects to receive a PEG) and then once at 8 weeks post-PEG placement.  
 
6. Any questions should be directed to Debra Suiter, PhD, CCC-SLP, (859) 218-5323 or 
debra.suiter@uky.edu. 
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ALS Functional Rating Scale – Bulbar Subscales 
Item 1: Speech 
4: Normal speech process 
3: Detectable speech disturbance 
2: Intelligible with repeating 
1: Speech combined with non-vocal communication 
0: Loss of useful speech 
Item 2: Salivation 
4: Normal 
3: Slight but definite excess of saliva in mouth, may have nighttime drooling 
2: Moderately excessive saliva; may have minimal drooling (during the day) 
1: Marked excess of saliva with some drooling 
0: Marked drooling; requires constant tissue or handkerchief 
Item 3: Swallowing 
4: Normal eating habits  
3: Early eating problems – occasional choking  
2: Dietary consistency changes  
1: Needs supplement tube feeding  
0: NPO (exclusively parenteral or enteral feeding) 
 
The ALS-FRS-R is also located at http://www.outcomes-umassmed.org/als/alsscale.aspx 
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1 
Consent to Participate in a Research Study 
The AWARE Study: Impact of Gastrostomy on Swallowing-Related Quality of Life in Patients with 
Amyotrophic Lateral Sclerosis and their Caregivers 
Caregiver Consent 
WHY ARE YOU BEING INVITED TO TAKE PART IN THIS RESEARCH? 
You are being invited to take part in a research study about how feeding tube placement affects quality of 
life (QOL) for patients and their caregivers. You are being invited to take part in this research study 
because you are a caregiver of an individual with ALS who is receiving medical care through our 
multidisciplinary clinic. If you volunteer to take part in this study, you will be one of about 25 caregivers to 
do so at the University of Kentucky.    
WHO IS DOING THE STUDY? 
The person in charge of this study is Debra Suiter, PhD of University of Kentucky, Department of 
Rehabilitation Sciences. There may be other people on the research team assisting at different times 
during the study.  
 
WHAT IS THE PURPOSE OF THIS STUDY? 
 
This study will examine the impact of feeding tube (PEG) placement on quality of life (QOL) of patients 
with amyotrophic lateral sclerosis (ALS) and their caregivers. Many patients with ALS experience difficulty 
swallowing, and healthcare providers often recommend a PEG tube to meet their nutrition and hydration 
needs. Receiving nutrition and hydration via a PEG is thought to improve nutritional balance, stabilize 
weight, and possibly extend the patient’s life.  
 
This study will examine patient and caregiver perceptions about QOL prior to and following PEG 
placement. We hope to learn some of the concerns of patients with ALS and their caregivers to enhance 
communication in the future regarding PEG tube use and nutritional intervention.  
 
ARE THERE REASONS WHY YOU SHOULD NOT TAKE PART IN THIS STUDY? 
There are no known reasons that you should not take part in this study. 
WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT LAST? 
  
The research procedures will be conducted at the Kentucky Neuroscience Institute. You will need to 
come to regularly scheduled clinic visit with the multidisciplinary ALS clinic. We will ask you to fill out 
questionnaires during today’s clinic visit. You will be mailed study questionnaires 2 weeks prior to the next 
clinic visit. The total amount of time necessary to complete the questionnaires is approximately 30 
minutes. We will collect those at each clinic visit prior to PEG placement and at one visit approximately 8 
weeks following PEG placement. The number of clinic visits prior to a patient deciding to choose PEG 
placement varies from patient to patient, but on average, patients are seen for 3 clinic visits prior to PEG 
placement. Thus, your total time for participation in this study is anticipated to be approximately 2 hours.  
 
WHAT WILL YOU BE ASKED TO DO? 
 
You will be asked to answer questions about how you perceive the swallowing ability of the person for 
whom you are caring. We will also ask you questions regarding your feelings related to caring for an 
individual with ALS.  
 
If you consent to participate in this study, we will give you these questionnaires at today’s clinic visit. After 
this visit, we will mail the questionnaires to you approximately 2 weeks prior to each of your clinic visits 
and ask you to bring them with you when you return to clinic.  
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WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS? 
There is a risk that your confidentiality may be breached. We will make every effort will be made to ensure 
the confidentiality of the responses you provide to our questionnaires. This includes assigning you a 
participant number that can be linked to your name on a participant list that will be kept in a locked filing 
cabinet in the Principal Investigator’s office (Room 124D Charles T. Wethington Building). We will also 
store all questionnaires in a locked filing cabinet in the Principal Investigator’s office. Data collected from 
the questionnaires will be entered into a computer file in a secured data base that only study personnel 
(the Principal Investigator and others involved in this research) will be able to access. No identifying 
information will be entered into this database.  
WILL YOU BENEFIT FROM TAKING PART IN THIS STUDY? 
You will not get any personal benefit from taking part in this study. 
DO YOU HAVE TO TAKE PART IN THE STUDY? 
If you decide to take part in the study, it should be because you really want to volunteer.  You will not lose 
any benefits or rights you would normally have if you choose not to volunteer.  You can stop at any time 
during the study and still keep the benefits and rights you had before volunteering.   
IF YOU DON’T WANT TO TAKE PART IN THE STUDY, ARE THERE OTHER CHOICES? 
If you do not want to be in the study, there are no other choices except not to take part in the study. 
 
WHAT WILL IT COST YOU TO PARTICIPATE? 
 
There will be no cost to you should you choose to participate in this study.  
WHO WILL SEE THE INFORMATION THAT YOU GIVE? 
We will make every effort to keep confidential all research records that identify you to the extent allowed 
by law. The answers you provide to the questionnaires will be stored in a secured database that is 
password protected and accessible only to study personnel including a research assistant and the 
Principal Investigator. 
 
Your information will be combined with information from other people taking part in the study. When we 
write about the study to share it with other researchers, we will write about the combined information we 
have gathered. You will not be personally identified in these written materials. We may publish the results 
of this study; however, we will keep you name and other identifying information private.  
We will make every effort to prevent anyone who is not on the research team from knowing that you gave 
us information, or what that information is. All paper copies of data will be stored in a locked filing cabinet 
in the Principal Investigator’s Office (Charles T. Wethington Building, Room 124D). Only the Principal 
Investigator will have information that will link your responses to your name. For all other data, you will be 
identified by a randomly assigned participant number. Data collected from all participants will be entered 
into a database called RedCap for analysis. Again, no identifying information that could link you to 
participation in this study will be included in this database.     
You should know, however, that there are some circumstances in which we may have to show your 
information to other people. For example, the law may require us to show your information to a court or to 
tell authorities if you pose a danger to yourself or someone else. Officials from the University of Kentucky 
may look at or copy pertinent portions of records that may identify you.      
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CAN YOUR TAKING PART IN THE STUDY END EARLY? 
If you decide to take part in the study you still have the right to decide at any time that you no longer want 
to continue. You will not be treated differently if you decide to stop taking part in the study. 
If you choose to withdraw from the study early, the data collected until that point will remain in the study 
database and may not be removed.   
ARE YOU PARTICIPATING OR CAN YOU PARTICIPATE IN ANOTHER RESEARCH STUDY AT THE 
SAME TIME AS PARTICIPATING IN THIS ONE? 
You may take part in this study if you are currently involved in another research study.  It is important to 
let the investigator/your doctor know if you are in another research study.  You should also discuss with 
the investigator before you agree to participate in another research study while you are enrolled in this 
study. 
WILL YOU RECEIVE ANY REWARDS FOR TAKING PART IN THIS STUDY? 
You will not receive any rewards or payment for taking part in the study.   
WHAT IF YOU HAVE QUESTIONS, SUGGESTIONS, CONCERNS, OR COMPLAINTS? 
Before you decide whether to accept this invitation to take part in the study, please ask any questions that 
might come to mind now.  Later, if you have questions, suggestions, concerns, or complaints about the 
study, you can contact the investigator, Debra Suiter at 859-218-5323.  If you have any questions about 
your rights as a volunteer in this research, contact the staff in the Office of Research Integrity between the 
business hours of 8am and 5pm EST, Mon-Fri at the University of Kentucky at 859-257-9428 or toll free 
at 1-866-400-9428. We will give you a signed copy of this consent form to take with you. 
 
WHAT IF NEW INFORMATION IS LEARNED DURING THE STUDY THAT MIGHT AFFECT YOUR 
DECISION TO PARTICIPATE? 
 
If the researcher learns of new information in regards to this study, and it might change your willingness 
to stay in this study, the information will be provided to you.  You may be asked to sign a new informed 
consent form if the information is provided to you after you have joined the study.  
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WHAT ELSE DO YOU NEED TO KNOW? 
There is a possibility that the data collected from you may be shared with other investigators in the future.  
If that is the case the data will not contain information that can identify you unless you give your 
consent/authorization or the UK Institutional Review Board (IRB) approves the research.  The IRB is a 
committee that reviews ethical issues, according to federal, state and local regulations on research with 
human subjects, to make sure the study complies with these before approval of a research study is 
issued. 
  
_____________________________________________                 ____________ 
Signature of person agreeing to take part in the study            Date 
  
_____________________________________________ 
Printed name of person agreeing to take part in the study 
  
_____________________________________________     ____________ 
Name of [authorized] person obtaining informed consent            Date 
  
_________________________________________ 
Signature of Principal Investigator or Sub/Co-Investigator   
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Combined Consent and Authorization to Participate in a Research Study  
The AWARE Study: Impact of Gastrostomy on Swallowing-Related Quality of Life in Patients with 
Amyotrophic Lateral Sclerosis and their Caregivers 
Patient Consent 
WHY ARE YOU BEING INVITED TO TAKE PART IN THIS RESEARCH? 
You are being invited to take part in a research study about how feeding tube placement affects quality of life 
(QOL) for patients with ALS and their caregivers. You are being invited to take part in this research study because 
you have been diagnosed with ALS and are being cared for at our multidisciplinary clinic. If you volunteer to take 
part in this study, you will be one of about 25 people with ALS at the University of Kentucky.    
 
WHO IS DOING THE STUDY? 
 
The person in charge of this study is Debra Suiter, PhD of University of Kentucky, Department of Rehabilitation 
Sciences. There may be other people on the research team assisting at different times during the study.  
 
WHAT IS THE PURPOSE OF THIS STUDY? 
 
This study will examine the impact of feeding tube (PEG) placement on quality of life (QOL) of patients with 
amyotrophic lateral sclerosis (ALS) and their caregivers. Many patients with ALS experience difficulty swallowing, 
and healthcare providers often recommend a PEG tube to meet their nutrition and hydration needs. Receiving 
nutrition and hydration via a PEG tube is thought to improve nutritional balance, stabilize weight, and possibly 
extend the patient’s life.  
 
This study will examine patient and caregiver perceptions about QOL prior to and following PEG placement. We 
hope to learn some of the concerns of patients with ALS and their families to enhance communication in the 
future regarding PEG tube use and nutritional intervention. 
 
ARE THERE REASONS WHY YOU SHOULD NOT TAKE PART IN THIS STUDY? 
There are no known reasons that you should not take part in this study.  
WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT LAST?  
The research procedures will be conducted at the Kentucky Neuroscience Institute. You will need to come to 
regularly scheduled clinic visit with the multidisciplinary ALS clinic. We will ask you to fill out questionnaires during 
today’s clinic visit. You will be mailed study questionnaires 2 weeks prior to the next clinic visit. The total amount 
of time necessary to complete the questionnaires is approximately 30 minutes. We will collect those at each clinic 
visit prior to PEG placement and at one visit approximately 8 weeks following PEG placement. The number of 
clinic visits prior to a patient deciding to choose PEG placement varies from patient to patient, but on average, 
patients are seen for 3 clinic visits prior to PEG placement. Thus, your total time for participation in this study is 
anticipated to be approximately 2 hours.  
WHAT WILL YOU BE ASKED TO DO? 
You will be asked to answer questions about how your swallowing ability affects your daily activities and how you 
feel about your swallowing ability. The person assisting in your care will be asked questions regarding how they 
feel about your swallowing ability. The questionnaires used for this study are designed to find out how swallowing 
difficulty affects quality of life.  
We will give you these questionnaires at today’s clinic visit if you decide to participate in this study. After this visit, 
we will mail the questionnaires to your home approximately 2 weeks prior to each of your clinic visits and ask you 
to bring them with you when you come to clinic. We will mail you another set of questionnaires approximately 8 
weeks following tube placement. 
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WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS? 
There is a risk that your confidentiality may be breached. We will make every effort to ensure the confidentiality of 
the responses you provide to our questionnaires. This includes assigning you a participant number that can be 
linked to your name on a participant list that will be kept in a locked filing cabinet in the Principal Investigator’s 
office (Room 124D Charles T. Wethington Building). We will also store all questionnaires in a locked filing cabinet 
in the Principal Investigator’s office. Data collected from the questionnaires will be entered into a computer file in a 
secured data base that only study personnel (the Principal Investigator and others involved in this research) will 
be able to access. No identifying information will be entered into this database.  
WILL YOU BENEFIT FROM TAKING PART IN THIS STUDY? 
You will not get any personal benefit from taking part in this study. Your willingness to take part, however, may, in 
the future, help doctors better understand and/or treat others who have ALS. 
DO YOU HAVE TO TAKE PART IN THE STUDY? 
If you decide to take part in the study, it should be because you really want to volunteer.  You will not lose any 
benefits or rights you would normally have if you choose not to volunteer.  You can stop at any time during the 
study and still keep the benefits and rights you had before volunteering.  If you decide not to take part in this 
study, your decision will have no effect on the quality of medical care you receive. 
 
IF YOU DON’T WANT TO TAKE PART IN THE STUDY, ARE THERE OTHER CHOICES? 
If you do not want to be in the study, there are no other choices except not to take part in the study. 
WHAT WILL IT COST YOU TO PARTICIPATE? 
You and/or your insurance company, Medicare or Medicaid will be responsible for the costs of all care and 
treatment you receive during this study that you would normally receive for your condition. These are costs that 
are considered medically reasonable and necessary and will be part of the care you receive if you do not take part 
in this study. There will be no additional costs to you for your participation in this study  
WHO WILL SEE THE INFORMATION THAT YOU GIVE? 
We will make every effort to keep confidential all research records that identify you to the extent allowed by law. 
The answers you provide to the questionnaires will be stored in a secured database that is password protected 
and accessible only to study personnel including a research assistant and the Principal Investigator. 
Your information will be combined with information from other people taking part in the study. When we write 
about the study to share it with other researchers, we will write about the combined information we have gathered. 
You will not be personally identified in these written materials. We may publish the results of this study; however, 
we will keep your name and other identifying information private.  
We will make every effort to prevent anyone who is not on the research team from knowing that you gave us 
information, or what that information is. All paper copies of data will be stored in a locked filing cabinet in the 
Principal Investigator’s office (CTW 124D). Only the Principal Investigator will have information that will link your 
identity to your information. For all other data, you will be identified by a randomly assigned participant number. 
Data collected from all participants will be entered into a database called RedCap for analysis. Again, no 
identifying information that could link you to participation in this study will be included in this database.    
You should know, however, that there are some circumstances in which we may have to show your information to 
other people. Officials of the University of Kentucky may look at or copy pertinent portions of records that identify 
you. 
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CAN YOUR TAKING PART IN THE STUDY END EARLY? 
If you decide to take part in the study, you still have the right to decide at any time that you no longer want to 
continue. You will not be treated differently if you decide to stop taking part in the study. 
If you choose to withdraw from the study early, the data collected until that point will remain in the study database 
and may not be removed.   
ARE YOU PARTICIPATING OR CAN YOU PARTICIPATE IN ANOTHER RESEARCH STUDY AT THE SAME 
TIME AS PARTICIPATING IN THIS ONE? 
You may take part in this study if you are currently involved in another research study.  It is important to let the 
investigator/your doctor know if you are in another research study.  You should also discuss with the investigator 
before you agree to participate in another research study while you are enrolled in this study. 
 
WHAT HAPPENS IF YOU GET HURT OR SICK DURING THE STUDY? 
If you believe you are hurt or if you get sick because of something that is due to the study, you should call Debra 
Suiter at 859-218-5323 immediately.  
 
It is important for you to understand that the University of Kentucky does not have funds set aside to pay for the 
cost of any care or treatment that might be necessary because you get hurt or sick while taking part in this study.  
Also, the University of Kentucky will not pay for any wages you may lose if you are harmed by this study.   
 
The medical costs related to your care and treatment because of research related harm will be your responsibility.  
You do not give up your legal rights by signing this form. 
 
 
WILL YOU RECEIVE ANY REWARDS FOR TAKING PART IN THIS STUDY? 
 
You will not get any rewards or payment for taking part in this study. 
 
WHAT IF YOU HAVE QUESTIONS, SUGGESTIONS, CONCERNS, OR COMPLAINTS? 
 
Before you decide whether to accept this invitation to take part in the study, please ask any questions that might 
come to mind now.  Later, if you have questions, suggestions, concerns, or complaints about the study, you can 
contact the investigator, Debra Suiter at 859-218-5323.  If you have any questions about your rights as a 
volunteer in this research, contact the staff in the Office of Research Integrity at the University of Kentucky 
between the business hours of 8am and 5pm EST, Mon-Fri at 859-257-9428 or toll free at 1-866-400-9428. We 
will give you a signed copy of this consent form to take with you. 
 
 
WHAT IF NEW INFORMATION IS LEARNED DURING THE STUDY THAT MIGHT AFFECT YOUR DECISION 
TO PARTICIPATE? 
 
If the researcher learns of new information in regards to this study, and it might change your willingness to stay in 
this study, the information will be provided to you.  You may be asked to sign a new informed consent form if the 
information is provided to you after you have joined the study.  
WHAT ELSE DO YOU NEED TO KNOW? 
There is a possibility that the data collected from you may be shared with other investigators in the future.  If that 
is the case the data will not contain information that can identify you unless you give your consent/authorization or 
the UK Institutional Review Board (IRB) approves the research.  The IRB is a committee that reviews ethical 
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issues, according to federal, state and local regulations on research with human subjects, to make sure the study 
complies with these before approval of a research study is issued. 
 
AUTHORIZATION TO USE OR DISCLOSE YOUR IDENTIFIABLE HEALTH INFORMATION  
 
The privacy law, HIPAA (Health Insurance Portability and Accountability Act), requires researchers to protect your 
health information.  The following sections of the form describe how researchers may use your health information.   
 
Your health information that may be accessed, used and/or released includes: 
 
• Gender, age, ALS-Functional Rating Scale data (which include information on speech, swallowing, 
and salivation), weight, height, body mass index, measures of lung function (forced vital capacity) 
 
The Researchers may use and share your health information with: 
 
• The University of Kentucky’s Institutional Review Board/Office of Research Integrity. 
• Law enforcement agencies when required by law. 
• University of Kentucky representatives. 
• UK Hospital 
 
The researchers agree to only share your health information with the people listed in this document.   
Should your health information be released to anyone that is not regulated by the privacy law, your health 
information may be shared with others without your permission; however, the use of your health information would 
still be regulated by applicable federal and state laws.   
You may not be allowed to participate in the research study if you do not sign this form.   If you decide not to sign 
the form, it will not affect your: 
• Current or future healthcare at the University of Kentucky 
• Current or future payments to the University of Kentucky   
• Ability to enroll in any health plans (if applicable) 
• Eligibility for benefits (if applicable) 
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After signing the form, you can change your mind and NOT let the researcher(s) collect or release your 
health information (revoke the Authorization). If you revoke the authorization: 
 
• You will send a written letter to: Debra Suiter, 900 S. Limestone Avenue, CTW 124D, Lexington, KY 
40536 to inform her of your decision. 
• Researchers may use and release your health information already collected for this research study. 
• Your protected health information may still be used and released should you have a bad reaction 
(adverse event). 
The use and sharing of your information has no time limit.  
 
If you have not already received a copy of the Privacy Notice, you may request one.  If you have any 
questions about your privacy rights, you should contact the University of Kentucky’s Privacy Officer 
between the business hours of 8am and 5pm EST, Mon-Fri at: (859) 323-1184. 
 
 
 
 
 
 
 
 
 
 
 
You are the subject or are authorized to act on behalf of the subject.  You have read this information, and 
you will receive a copy of this form after it is signed. 
 
 
_______________________________________   
Signature of Research Subject or Witness  
 
_____________________________________________________    
Printed name of research subject and Witness (if applicable) 
 
 
________________________________________________________________          _________ 
Name of [authorized] person obtaining informed consent/HIPAA authorization     Date 
  
 
_________________________________________ 
Signature of Principal Investigator or Sub/Co-Investigator 
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Appendix C:  Modified Caregiver Strain Index (MCSI) 
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Appendix D:  Eating Assessment Tool (EAT-10) 
 
 
EATING ASSESSMENT TOOL (EAT-10) 
 
 
Name: ________________________________ ________ EMR# _______________ 
 
Birthdate/Age: _____________________________  Todays Date: ______________  
 
The purpose of the EAT-10 questions is to help measure swallowing problems.  
Answer each question by circling the number that matches how bad you feel the 
problem is for you. 
 
To what degree to you experience the 
following problems?   
Circle an answer between 0 and 4 
0 = No problem   4 = Severe problem
 
1. My swallowing problem has caused me to 
lose weight. 
0 1 2 3 4
2. My swallowing problem interferes with my 
ability to go out for meals. 
0 1 2 3 4
3. Swallowing liquids takes extra effort. 0 1 2 3 4
4. Swallowing solids takes extra effort. 0 1 2 3 4
5. Swallowing pills takes extra effort. 0 1 2 3 4
6. Swallowing is painful. 0 1 2 3 4
7. The pleasure of eating is affected by my 
swallowing. 
0 1 2 3 4
8. When I swallow food sticks in my throat. 0 1 2 3 4
9. I cough when I eat. 0 1 2 3 4
10. Swallowing is stressful 0 1 2 3 4
 
Add up the sum of the numbers you circled for a TOTAL EAT-10 Score:
 
If your score is greater than 3 you may have swallowing problems .  We 
suggest that you share your EAT-10 results with your doctor. 
 
 
 
 
Reference: Belafky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Alen J and Leonard RJ. Validity and 
reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol 2008; 117(12):919-924. 
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Appendix E:  Swallowing-Related Quality of Life Instrument (SWAL-QOL) 
 
 
Understanding
Quality of Life
 in Swallowing Disorders
The SWAL-QOL SURVEY
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IMPORTANT NOTE: We understand that you may have a number of physical problems.
Sometimes it is hard to separate these from swallowing difficulties, but we hope that you
can do your best to concentrate only on your swallowing problem.   Thank you for your
efforts in completing this questionnaire.
1. Below are some general statements that people with swallowing problems might
mention. In the last month, how true have the following statements been for you.
(circle one number on each line)
Very much
true
Quite a bit
true
Somewhat
true
A little
true
Not at
all true
Dealing with my
swallowing problem is
very difficult.
1 2 3 4 5
My swallowing problem is
a major distraction in my
life.
1 2 3 4 5
2. Below are aspects of day-to-day eating that people with swallowing problems
sometimes talk about. In the last month, how true have the following statements
been for you?
(circle one number on each line)
Very much
true
Quite a bit
true
Somewhat
true
A little
true
Not at
all true
Most days, I don’t care if I
eat or not.
1 2 3 4 5
It takes me longer to eat
than other people.
1 2 3 4 5
I’m rarely hungry
anymore.
1 2 3 4 5
It takes me forever to eat
a meal.
1 2 3 4 5
I don’t enjoy eating
anymore.
1 2 3 4 5
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3. Below are some physical problems that people with swallowing problems
sometimes experience. In the last month, how often you have experienced each
problem as a result of your swallowing problem?
(circle one number on each line)
Almost
always
Often Sometimes Hardly
ever
Never
Coughing 1 2 3 4 5
Choking when you eat food 1 2 3 4 5
Choking when you take
liquids
1 2 3 4 5
Having thick saliva or phlegm 1 2 3 4 5
Gagging 1 2 3 4 5
Drooling 1 2 3 4 5
Problems chewing 1 2 3 4 5
Having excess saliva or
phlegm
1 2 3 4 5
Having to clear your throat 1 2 3 4 5
Food sticking in your throat 1 2 3 4 5
Food sticking in your mouth 1 2 3 4 5
Food or liquid dribbling out of
your mouth 1 2 3 4 5
Food or liquid coming out
your nose 1 2 3 4 5
Coughing food or liquid out of
your mouth when it gets stuck 1 2 3 4 5
4. Next, please answer a few questions about how your swallowing problem has
affected your diet and eating in the last month.
(circle one number on each line)
Strongly
agree
Agree Uncertain Disagree Strongly
disagree
Figuring out what I can and can’t
eat is a problem for me.
1 2 3 4 5
It is difficult to find foods that I
both like and can eat.
1 2 3 4 5
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5. In the last month, how often have the following statements about communication
applied to you because of your swallowing problem?
(circle one number on each line)
All of
the time
Most of
the time
Some of
the time
A little of
the time
None of
the time
People have a hard time
understanding me. 1 2 3 4 5
It’s been difficult for me to
speak clearly. 1 2 3 4 5
6. Below are some concerns that people with swallowing problems  sometimes
mention. In the last month, how often have you experienced each feeling?
(circle one number on each line)
Almost
always
Often Sometimes Hardly
ever
Never
I fear I may start choking when I
eat food.
1 2 3 4 5
I worry about getting pneumonia. 1 2 3 4 5
I am afraid of choking when I drink
liquids. 1 2 3 4 5
I never know when I am going to
choke.
1 2 3 4 5
7. In the last month, how often have the following statements been true for you because
of your swallowing problem?
(circle one number on each line)
Always
true
Often
true
Sometimes
true
Hardly
ever true
Never
true
My swallowing problem
depresses me.
1 2 3 4 5
Having to be so careful when
I eat or drink annoys me.
1 2 3 4 5
I’ve been discouraged by my
swallowing problem.
1 2 3 4 5
My swallowing problem
frustrates me.
1 2 3 4 5
I get impatient dealing with
my swallowing problem.
1 2 3 4 5
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8. Think about your social life in the last month. How strongly would you agree or
disagree with the following statements?
(circle one number on each line)
Strongly
agree
Agree Uncertain Disagree Strongly
disagree
I do not go out to eat because
of my swallowing problem.
1 2 3 4 5
My swallowing problem makes
it hard to have a social life.
1 2 3 4 5
My usual work or leisure
activities have changed
because of my swallowing
problem.
1 2 3 4 5
Social gatherings (like holidays
or get-togethers) are not
enjoyable because of my
swallowing problem.
1 2 3 4 5
My role with family and friends
has changed because of my
swallowing problem.
1 2 3 4 5
9. In the last month, how often have you experienced each of the following physical
symptoms?
(circle one number on each line)
All of
the time
Most of
the time
Some of
the time
A little of
the time
None of
the time
Feel weak? 1 2 3 4 5
Have trouble falling asleep? 1 2 3 4 5
Feel tired? 1 2 3 4 5
Have trouble staying asleep? 1 2 3 4 5
Feel exhausted? 1 2 3 4 5
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10. Do you now take any food or liquid through a feeding tube?
(circle one)
No ................................................................................................................ 1
Yes............................................................................................................... 2
11. Please circle the letter of the one description below that best describes the
consistency or texture of the food you have been eating most often in the last week.
Circle one:
A.  Circle this one if you are eating a full normal diet, which would include a wide
variety of foods, including hard to chew items like steak, carrots, bread, salad,
and popcorn.
B.  Circle this one if you are eating soft, easy to chew foods like casseroles, canned
fruits, soft cooked vegetables, ground meat, or cream soups.
C.  Circle this one if you are eating food that is put through a blender or food
processor or anything that is like pudding or pureed foods.
D.  Circle this one if you take most of your nutrition by tube, but sometimes eat ice
cream, pudding, apple sauce, or other pleasure foods.
E.  Circle this one if you take all of your nourishment through a tube.
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12. Please circle the letter of the one description below that best describes the
consistency of liquids you have been drinking most often in the last week.
Circle one:
A.  Circle this if you drink liquids such as water, milk, tea, fruit juice, and coffee.
B.  Circle this if the majority of liquids you drink are thick, like tomato juice or apricot
nectar.  Such thick liquids drip off your spoon in a slow steady stream when you
turn it upside down.
C.  Circle this if your liquids are moderately thick, like a thick milkshake or smoothie.
Such moderately thick liquids are difficult to suck through a straw, like a very
thick milkshake, or drip off your spoon slowly drop by drop when you turn it
upside down, such as honey.
D.  Circle this if your liquids are very thick, like pudding.  Such very thick liquids will
stick to a spoon when you turn it upside down, such as pudding.
E.  Circle this if you did not take any liquids by mouth or if you have been limited to
ice chips.
13. In general, would you say your health is:
(circle one)
Poor ........................................................................................................... 1
Fair............................................................................................................. 2
Good.......................................................................................................... 3
Very Good.................................................................................................. 4
Excellent .................................................................................................... 5
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